NZ778750B2 - Charge-bearing cyclodextrin polymeric materials and methods of making and using same - Google Patents
Charge-bearing cyclodextrin polymeric materials and methods of making and using same Download PDFInfo
- Publication number
- NZ778750B2 NZ778750B2 NZ778750A NZ77875020A NZ778750B2 NZ 778750 B2 NZ778750 B2 NZ 778750B2 NZ 778750 A NZ778750 A NZ 778750A NZ 77875020 A NZ77875020 A NZ 77875020A NZ 778750 B2 NZ778750 B2 NZ 778750B2
- Authority
- NZ
- New Zealand
- Prior art keywords
- porous polymeric
- polymeric material
- cyclodextrin
- porous
- cdp
- Prior art date
Links
- 239000000463 material Substances 0.000 title claims abstract description 173
- 229920000858 Cyclodextrin Polymers 0.000 title claims abstract description 85
- 238000000034 method Methods 0.000 title claims abstract description 63
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 title claims description 53
- 229940097362 cyclodextrins Drugs 0.000 claims abstract description 37
- 239000012530 fluid Substances 0.000 claims abstract description 22
- 238000002414 normal-phase solid-phase extraction Methods 0.000 claims abstract 3
- 125000005647 linker group Chemical group 0.000 claims description 59
- 150000001875 compounds Chemical class 0.000 claims description 49
- 125000003118 aryl group Chemical group 0.000 claims description 31
- 125000002091 cationic group Chemical group 0.000 claims description 27
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims description 22
- 239000003344 environmental pollutant Substances 0.000 claims description 16
- 231100000719 pollutant Toxicity 0.000 claims description 15
- 239000002904 solvent Substances 0.000 claims description 14
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 11
- 125000000732 arylene group Chemical group 0.000 claims description 11
- 238000011534 incubation Methods 0.000 claims description 11
- 150000001768 cations Chemical class 0.000 claims description 10
- 238000010438 heat treatment Methods 0.000 claims description 10
- 125000000217 alkyl group Chemical group 0.000 claims description 9
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 9
- 125000001072 heteroaryl group Chemical group 0.000 claims description 8
- 229910052736 halogen Inorganic materials 0.000 claims description 6
- 125000001188 haloalkyl group Chemical group 0.000 claims description 5
- 125000005549 heteroarylene group Chemical group 0.000 claims description 5
- 229910052751 metal Inorganic materials 0.000 claims description 4
- 239000002184 metal Substances 0.000 claims description 4
- 241000257303 Hymenoptera Species 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims description 2
- 239000000976 ink Substances 0.000 claims description 2
- 239000001116 FEMA 4028 Substances 0.000 claims 7
- 235000011175 beta-cyclodextrine Nutrition 0.000 claims 7
- 229960004853 betadex Drugs 0.000 claims 7
- 125000003161 (C1-C6) alkylene group Chemical group 0.000 claims 3
- 229910006069 SO3H Inorganic materials 0.000 claims 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 1
- 229920000642 polymer Polymers 0.000 description 118
- 239000000835 fiber Substances 0.000 description 108
- 238000004637 computerized dynamic posturography Methods 0.000 description 103
- 239000002245 particle Substances 0.000 description 83
- 239000000758 substrate Substances 0.000 description 57
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 45
- -1 t—hutyl Chemical group 0.000 description 43
- 238000001179 sorption measurement Methods 0.000 description 37
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 36
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 35
- 125000000129 anionic group Chemical group 0.000 description 32
- 239000000203 mixture Substances 0.000 description 30
- 239000003463 adsorbent Substances 0.000 description 27
- 101001136034 Homo sapiens Phosphoribosylformylglycinamidine synthase Proteins 0.000 description 26
- 102100036473 Phosphoribosylformylglycinamidine synthase Human genes 0.000 description 26
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 25
- 239000011230 binding agent Substances 0.000 description 24
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 24
- 239000000843 powder Substances 0.000 description 24
- 210000001233 cdp Anatomy 0.000 description 22
- 238000006243 chemical reaction Methods 0.000 description 20
- 239000000356 contaminant Substances 0.000 description 19
- 230000008569 process Effects 0.000 description 19
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 description 18
- 235000019743 Choline chloride Nutrition 0.000 description 18
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 description 18
- 229960003178 choline chloride Drugs 0.000 description 18
- 239000006185 dispersion Substances 0.000 description 18
- 239000000460 chlorine Substances 0.000 description 17
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 16
- 239000002253 acid Substances 0.000 description 16
- 150000001412 amines Chemical class 0.000 description 16
- 229960001231 choline Drugs 0.000 description 16
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 16
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 16
- SNGREZUHAYWORS-UHFFFAOYSA-N perfluorooctanoic acid Chemical compound OC(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F SNGREZUHAYWORS-UHFFFAOYSA-N 0.000 description 16
- 239000000243 solution Substances 0.000 description 16
- 229920002678 cellulose Polymers 0.000 description 15
- 238000001914 filtration Methods 0.000 description 15
- 239000000126 substance Substances 0.000 description 15
- 239000004744 fabric Substances 0.000 description 14
- 125000000524 functional group Chemical group 0.000 description 13
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 13
- 239000012528 membrane Substances 0.000 description 13
- PCRSJGWFEMHHEW-UHFFFAOYSA-N 2,3,5,6-tetrafluorobenzene-1,4-dicarbonitrile Chemical compound FC1=C(F)C(C#N)=C(F)C(F)=C1C#N PCRSJGWFEMHHEW-UHFFFAOYSA-N 0.000 description 12
- 230000015572 biosynthetic process Effects 0.000 description 12
- 239000001913 cellulose Substances 0.000 description 12
- 235000010980 cellulose Nutrition 0.000 description 12
- 239000004971 Cross linker Substances 0.000 description 11
- 125000005442 diisocyanate group Chemical group 0.000 description 10
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 10
- 238000004710 electron pair approximation Methods 0.000 description 10
- 238000003786 synthesis reaction Methods 0.000 description 10
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 9
- IISBACLAFKSPIT-UHFFFAOYSA-N bisphenol A Chemical compound C=1C=C(O)C=CC=1C(C)(C)C1=CC=C(O)C=C1 IISBACLAFKSPIT-UHFFFAOYSA-N 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 125000004076 pyridyl group Chemical group 0.000 description 9
- 125000001424 substituent group Chemical group 0.000 description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 8
- 150000005857 PFAS Chemical class 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 8
- 238000011068 loading method Methods 0.000 description 8
- 238000003801 milling Methods 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 7
- 125000003277 amino group Chemical group 0.000 description 7
- 239000007789 gas Substances 0.000 description 7
- 239000008187 granular material Substances 0.000 description 7
- 239000012948 isocyanate Substances 0.000 description 7
- 150000002513 isocyanates Chemical class 0.000 description 7
- 229920005989 resin Polymers 0.000 description 7
- 239000011347 resin Substances 0.000 description 7
- 239000004698 Polyethylene Substances 0.000 description 6
- 229920002472 Starch Polymers 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 238000000576 coating method Methods 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 229920001778 nylon Polymers 0.000 description 6
- 239000012071 phase Substances 0.000 description 6
- 229920000573 polyethylene Polymers 0.000 description 6
- 239000008107 starch Substances 0.000 description 6
- 235000019698 starch Nutrition 0.000 description 6
- 239000004753 textile Substances 0.000 description 6
- 150000003573 thiols Chemical class 0.000 description 6
- 101000945442 Homo sapiens Kelch domain-containing protein 3 Proteins 0.000 description 5
- 102100033602 Kelch domain-containing protein 3 Human genes 0.000 description 5
- 240000004713 Pisum sativum Species 0.000 description 5
- 235000010582 Pisum sativum Nutrition 0.000 description 5
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 5
- 235000013877 carbamide Nutrition 0.000 description 5
- 229910052799 carbon Inorganic materials 0.000 description 5
- 239000011248 coating agent Substances 0.000 description 5
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 5
- 238000010348 incorporation Methods 0.000 description 5
- 230000003993 interaction Effects 0.000 description 5
- 150000002500 ions Chemical class 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 230000007246 mechanism Effects 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 150000002894 organic compounds Chemical class 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- 239000013618 particulate matter Substances 0.000 description 5
- 239000011148 porous material Substances 0.000 description 5
- 229920006395 saturated elastomer Polymers 0.000 description 5
- 150000003384 small molecules Chemical class 0.000 description 5
- 241000894007 species Species 0.000 description 5
- 229920001169 thermoplastic Polymers 0.000 description 5
- 239000004416 thermosoftening plastic Substances 0.000 description 5
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 4
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 4
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- 239000004677 Nylon Substances 0.000 description 4
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 4
- 229920000297 Rayon Polymers 0.000 description 4
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 4
- 238000001994 activation Methods 0.000 description 4
- 230000004913 activation Effects 0.000 description 4
- 125000002947 alkylene group Chemical group 0.000 description 4
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 125000004429 atom Chemical group 0.000 description 4
- 239000004305 biphenyl Substances 0.000 description 4
- 235000010290 biphenyl Nutrition 0.000 description 4
- 239000004202 carbamide Substances 0.000 description 4
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- 238000005345 coagulation Methods 0.000 description 4
- 230000015271 coagulation Effects 0.000 description 4
- 239000012043 crude product Substances 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- LEQAOMBKQFMDFZ-UHFFFAOYSA-N glyoxal Chemical compound O=CC=O LEQAOMBKQFMDFZ-UHFFFAOYSA-N 0.000 description 4
- 238000005469 granulation Methods 0.000 description 4
- 230000003179 granulation Effects 0.000 description 4
- 239000003673 groundwater Substances 0.000 description 4
- 239000012510 hollow fiber Substances 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000000178 monomer Substances 0.000 description 4
- 125000001624 naphthyl group Chemical group 0.000 description 4
- 239000004745 nonwoven fabric Substances 0.000 description 4
- 125000004430 oxygen atom Chemical group O* 0.000 description 4
- 229920000728 polyester Polymers 0.000 description 4
- 229920000139 polyethylene terephthalate Polymers 0.000 description 4
- 239000005020 polyethylene terephthalate Substances 0.000 description 4
- 229920002635 polyurethane Polymers 0.000 description 4
- 239000004814 polyurethane Substances 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 4
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 4
- 125000001453 quaternary ammonium group Chemical group 0.000 description 4
- 229920001059 synthetic polymer Polymers 0.000 description 4
- OGNVQLDIPUXYDH-ZPKKHLQPSA-N (2R,3R,4S)-3-(2-methylpropanoylamino)-4-(4-phenyltriazol-1-yl)-2-[(1R,2R)-1,2,3-trihydroxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acid Chemical compound CC(C)C(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CO)OC(C(O)=O)=C[C@@H]1N1N=NC(C=2C=CC=CC=2)=C1 OGNVQLDIPUXYDH-ZPKKHLQPSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 229920000742 Cotton Polymers 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 150000001735 carboxylic acids Chemical class 0.000 description 3
- 235000013601 eggs Nutrition 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 125000002541 furyl group Chemical group 0.000 description 3
- 150000004820 halides Chemical group 0.000 description 3
- 229910010272 inorganic material Inorganic materials 0.000 description 3
- 239000011147 inorganic material Substances 0.000 description 3
- 230000010354 integration Effects 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- STZCRXQWRGQSJD-GEEYTBSJSA-M methyl orange Chemical compound [Na+].C1=CC(N(C)C)=CC=C1\N=N\C1=CC=C(S([O-])(=O)=O)C=C1 STZCRXQWRGQSJD-GEEYTBSJSA-M 0.000 description 3
- 229940012189 methyl orange Drugs 0.000 description 3
- CXKWCBBOMKCUKX-UHFFFAOYSA-M methylene blue Chemical compound [Cl-].C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 CXKWCBBOMKCUKX-UHFFFAOYSA-M 0.000 description 3
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 3
- 229960000907 methylthioninium chloride Drugs 0.000 description 3
- 229940016286 microcrystalline cellulose Drugs 0.000 description 3
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 3
- 239000008108 microcrystalline cellulose Substances 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 239000012038 nucleophile Substances 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 229920001228 polyisocyanate Polymers 0.000 description 3
- 239000005056 polyisocyanate Substances 0.000 description 3
- 238000006116 polymerization reaction Methods 0.000 description 3
- 229920002451 polyvinyl alcohol Polymers 0.000 description 3
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 3
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 3
- 125000006413 ring segment Chemical group 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 230000009919 sequestration Effects 0.000 description 3
- 239000000377 silicon dioxide Substances 0.000 description 3
- 239000002002 slurry Substances 0.000 description 3
- 239000002689 soil Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000002594 sorbent Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N toluene Substances CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- 125000004306 triazinyl group Chemical group 0.000 description 3
- 229920000785 ultra high molecular weight polyethylene Polymers 0.000 description 3
- 239000012808 vapor phase Substances 0.000 description 3
- 239000012855 volatile organic compound Substances 0.000 description 3
- 239000002759 woven fabric Substances 0.000 description 3
- YBYIRNPNPLQARY-UHFFFAOYSA-N 1H-indene Natural products C1=CC=C2CC=CC2=C1 YBYIRNPNPLQARY-UHFFFAOYSA-N 0.000 description 2
- CSEBNABAWMZWIF-UHFFFAOYSA-N 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)propanoic acid Chemical compound OC(=O)C(F)(C(F)(F)F)OC(F)(F)C(F)(F)C(F)(F)F CSEBNABAWMZWIF-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 229920000049 Carbon (fiber) Polymers 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Divinylene sulfide Natural products C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 2
- 239000004593 Epoxy Substances 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 2
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 2
- 239000005977 Ethylene Substances 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 101100518501 Mus musculus Spp1 gene Proteins 0.000 description 2
- 229920002302 Nylon 6,6 Polymers 0.000 description 2
- 239000002033 PVDF binder Substances 0.000 description 2
- 239000004952 Polyamide Substances 0.000 description 2
- 229920002873 Polyethylenimine Polymers 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- 229920001131 Pulp (paper) Polymers 0.000 description 2
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 2
- 239000004699 Ultra-high molecular weight polyethylene Substances 0.000 description 2
- MCMNRKCIXSYSNV-UHFFFAOYSA-N Zirconium dioxide Chemical compound O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 description 2
- 229920005822 acrylic binder Polymers 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 125000002178 anthracenyl group Chemical group C1(=CC=CC2=CC3=CC=CC=C3C=C12)* 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 239000006286 aqueous extract Substances 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 229910052786 argon Inorganic materials 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 125000006267 biphenyl group Chemical group 0.000 description 2
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 2
- 239000004917 carbon fiber Substances 0.000 description 2
- 239000003575 carbonaceous material Substances 0.000 description 2
- 229920002301 cellulose acetate Polymers 0.000 description 2
- 229920003086 cellulose ether Polymers 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000005229 chemical vapour deposition Methods 0.000 description 2
- 239000000149 chemical water pollutant Substances 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- 239000003431 cross linking reagent Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 239000003651 drinking water Substances 0.000 description 2
- 235000020188 drinking water Nutrition 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000009977 dual effect Effects 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 238000000921 elemental analysis Methods 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 239000005038 ethylene vinyl acetate Substances 0.000 description 2
- 238000001125 extrusion Methods 0.000 description 2
- 238000005189 flocculation Methods 0.000 description 2
- 230000016615 flocculation Effects 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 238000004817 gas chromatography Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 229940015043 glyoxal Drugs 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 150000002367 halogens Chemical class 0.000 description 2
- 125000000623 heterocyclic group Chemical group 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 125000003392 indanyl group Chemical group C1(CCC2=CC=CC=C12)* 0.000 description 2
- 125000003454 indenyl group Chemical group C1(C=CC2=CC=CC=C12)* 0.000 description 2
- 125000003387 indolinyl group Chemical group N1(CCC2=CC=CC=C12)* 0.000 description 2
- 238000009434 installation Methods 0.000 description 2
- 230000001788 irregular Effects 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 238000004949 mass spectrometry Methods 0.000 description 2
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 238000001471 micro-filtration Methods 0.000 description 2
- 229920005615 natural polymer Polymers 0.000 description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 description 2
- 235000019645 odor Nutrition 0.000 description 2
- 229910000073 phosphorus hydride Inorganic materials 0.000 description 2
- 229920003254 poly(benzobisthiazole) Polymers 0.000 description 2
- 229920002492 poly(sulfone) Polymers 0.000 description 2
- 229920002647 polyamide Polymers 0.000 description 2
- 229920000867 polyelectrolyte Polymers 0.000 description 2
- 239000002861 polymer material Substances 0.000 description 2
- 229920000098 polyolefin Polymers 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 235000015320 potassium carbonate Nutrition 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 125000003373 pyrazinyl group Chemical group 0.000 description 2
- 239000002964 rayon Substances 0.000 description 2
- 239000000376 reactant Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 239000004627 regenerated cellulose Substances 0.000 description 2
- 238000001223 reverse osmosis Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 150000004760 silicates Chemical class 0.000 description 2
- 239000007790 solid phase Substances 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 229920002994 synthetic fiber Polymers 0.000 description 2
- 239000012209 synthetic fiber Substances 0.000 description 2
- 125000000335 thiazolyl group Chemical group 0.000 description 2
- 229930192474 thiophene Natural products 0.000 description 2
- DVKJHBMWWAPEIU-UHFFFAOYSA-N toluene 2,4-diisocyanate Chemical group CC1=CC=C(N=C=O)C=C1N=C=O DVKJHBMWWAPEIU-UHFFFAOYSA-N 0.000 description 2
- 150000003673 urethanes Chemical class 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 239000002351 wastewater Substances 0.000 description 2
- MTZUIIAIAKMWLI-UHFFFAOYSA-N 1,2-diisocyanatobenzene Chemical compound O=C=NC1=CC=CC=C1N=C=O MTZUIIAIAKMWLI-UHFFFAOYSA-N 0.000 description 1
- OVBFMUAFNIIQAL-UHFFFAOYSA-N 1,4-diisocyanatobutane Chemical compound O=C=NCCCCN=C=O OVBFMUAFNIIQAL-UHFFFAOYSA-N 0.000 description 1
- ATOUXIOKEJWULN-UHFFFAOYSA-N 1,6-diisocyanato-2,2,4-trimethylhexane Chemical compound O=C=NCCC(C)CC(C)(C)CN=C=O ATOUXIOKEJWULN-UHFFFAOYSA-N 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- WLODWTPNUWYZKN-UHFFFAOYSA-N 1h-pyrrol-2-ol Chemical compound OC1=CC=CN1 WLODWTPNUWYZKN-UHFFFAOYSA-N 0.000 description 1
- OVSKIKFHRZPJSS-DOMIDYPGSA-N 2-(2,4-dichlorophenoxy)acetic acid Chemical compound OC(=O)[14CH2]OC1=CC=C(Cl)C=C1Cl OVSKIKFHRZPJSS-DOMIDYPGSA-N 0.000 description 1
- WNTGYJSOUMFZEP-UHFFFAOYSA-N 2-(4-chloro-2-methylphenoxy)propanoic acid Chemical compound OC(=O)C(C)OC1=CC=C(Cl)C=C1C WNTGYJSOUMFZEP-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- GDTSJMKGXGJFGQ-UHFFFAOYSA-N 3,7-dioxido-2,4,6,8,9-pentaoxa-1,3,5,7-tetraborabicyclo[3.3.1]nonane Chemical compound O1B([O-])OB2OB([O-])OB1O2 GDTSJMKGXGJFGQ-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 229920001450 Alpha-Cyclodextrin Polymers 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 101100351932 Aspergillus awamori pgaA gene Proteins 0.000 description 1
- 101100460714 Aspergillus sp. (strain MF297-2) notN gene Proteins 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 1
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 229920013683 Celanese Polymers 0.000 description 1
- 101000654316 Centruroides limpidus Beta-toxin Cll2 Proteins 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 244000153665 Ficus glomerata Species 0.000 description 1
- 235000012571 Ficus glomerata Nutrition 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- 241000588731 Hafnia Species 0.000 description 1
- 239000005057 Hexamethylene diisocyanate Substances 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- 229930184624 Ideamine Natural products 0.000 description 1
- 229920006309 Invista Polymers 0.000 description 1
- 229920000106 Liquid crystal polymer Polymers 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 239000005574 MCPA Substances 0.000 description 1
- 229920000877 Melamine resin Polymers 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- UJURFSDRMQAYSU-UHFFFAOYSA-N N=C=O.N=C=O.C1=CC=CC2=C(C=CC=C3)C3=C21 Chemical compound N=C=O.N=C=O.C1=CC=CC2=C(C=CC=C3)C3=C21 UJURFSDRMQAYSU-UHFFFAOYSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- CMWTZPSULFXXJA-UHFFFAOYSA-N Naproxen Natural products C1=C(C(C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 229920002292 Nylon 6 Polymers 0.000 description 1
- 240000001155 Opuntia dillenii Species 0.000 description 1
- 235000006544 Opuntia dillenii Nutrition 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000286209 Phasianidae Species 0.000 description 1
- 239000004695 Polyether sulfone Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Chemical compound CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 1
- 102000005583 Pyrin Human genes 0.000 description 1
- 108010059278 Pyrin Proteins 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 239000004902 Softening Agent Substances 0.000 description 1
- 235000015125 Sterculia urens Nutrition 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- WHKUVVPPKQRRBV-UHFFFAOYSA-N Trasan Chemical compound CC1=CC(Cl)=CC=C1OCC(O)=O WHKUVVPPKQRRBV-UHFFFAOYSA-N 0.000 description 1
- 229920000508 Vectran Polymers 0.000 description 1
- 239000004979 Vectran Substances 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 1
- LUTSRLYCMSCGCS-BWOMAWGNSA-N [(3s,8r,9s,10r,13s)-10,13-dimethyl-17-oxo-1,2,3,4,7,8,9,11,12,16-decahydrocyclopenta[a]phenanthren-3-yl] acetate Chemical compound C([C@@H]12)C[C@]3(C)C(=O)CC=C3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)C)C1 LUTSRLYCMSCGCS-BWOMAWGNSA-N 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 239000003570 air Substances 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 150000001345 alkine derivatives Chemical class 0.000 description 1
- 150000004703 alkoxides Chemical class 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- HFHDHCJBZVLPGP-RWMJIURBSA-N alpha-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 description 1
- 229940043377 alpha-cyclodextrin Drugs 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 229920001448 anionic polyelectrolyte Polymers 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000006265 aqueous foam Substances 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000004760 aramid Substances 0.000 description 1
- 229920006231 aramid fiber Polymers 0.000 description 1
- 125000002029 aromatic hydrocarbon group Chemical group 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 125000004619 benzopyranyl group Chemical group O1C(C=CC2=C1C=CC=C2)* 0.000 description 1
- 239000013060 biological fluid Substances 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 230000005587 bubbling Effects 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- DQXBYHZEEUGOBF-UHFFFAOYSA-N but-3-enoic acid;ethene Chemical compound C=C.OC(=O)CC=C DQXBYHZEEUGOBF-UHFFFAOYSA-N 0.000 description 1
- MTAZNLWOLGHBHU-UHFFFAOYSA-N butadiene-styrene rubber Chemical compound C=CC=C.C=CC1=CC=CC=C1 MTAZNLWOLGHBHU-UHFFFAOYSA-N 0.000 description 1
- 238000003490 calendering Methods 0.000 description 1
- 235000009120 camo Nutrition 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 125000002843 carboxylic acid group Chemical group 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 238000009960 carding Methods 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 235000005607 chanvre indien Nutrition 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 238000013375 chromatographic separation Methods 0.000 description 1
- 229920000891 common polymer Polymers 0.000 description 1
- 239000011365 complex material Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 229940099112 cornstarch Drugs 0.000 description 1
- 238000003851 corona treatment Methods 0.000 description 1
- 150000005676 cyclic carbonates Chemical class 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000000280 densification Methods 0.000 description 1
- 238000010612 desalination reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- CRPOUZQWHJYTMS-UHFFFAOYSA-N dialuminum;magnesium;disilicate Chemical compound [Mg+2].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] CRPOUZQWHJYTMS-UHFFFAOYSA-N 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000003618 dip coating Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000009510 drug design Methods 0.000 description 1
- 238000009837 dry grinding Methods 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000003821 enantio-separation Methods 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 239000004715 ethylene vinyl alcohol Substances 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- ZHNUHDYFZUAESO-UHFFFAOYSA-N formamide Substances NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 238000007306 functionalization reaction Methods 0.000 description 1
- GDSRMADSINPKSL-HSEONFRVSA-N gamma-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO GDSRMADSINPKSL-HSEONFRVSA-N 0.000 description 1
- 229940080345 gamma-cyclodextrin Drugs 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229910021389 graphene Inorganic materials 0.000 description 1
- CJNBYAVZURUTKZ-UHFFFAOYSA-N hafnium(IV) oxide Inorganic materials O=[Hf]=O CJNBYAVZURUTKZ-UHFFFAOYSA-N 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 239000011121 hardwood Substances 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 239000011487 hemp Substances 0.000 description 1
- 231100000234 hepatic damage Toxicity 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- RRAMGCGOFNQTLD-UHFFFAOYSA-N hexamethylene diisocyanate Chemical compound O=C=NCCCCCCN=C=O RRAMGCGOFNQTLD-UHFFFAOYSA-N 0.000 description 1
- 229920006253 high performance fiber Polymers 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- NRXQIUSYPAHGNM-UHFFFAOYSA-N ioxynil Chemical compound OC1=C(I)C=C(C#N)C=C1I NRXQIUSYPAHGNM-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- IQPQWNKOIGAROB-UHFFFAOYSA-N isocyanate group Chemical group [N-]=C=O IQPQWNKOIGAROB-UHFFFAOYSA-N 0.000 description 1
- YDNLNVZZTACNJX-UHFFFAOYSA-N isocyanatomethylbenzene Chemical compound O=C=NCC1=CC=CC=C1 YDNLNVZZTACNJX-UHFFFAOYSA-N 0.000 description 1
- ZFSLODLOARCGLH-UHFFFAOYSA-N isocyanuric acid Chemical compound OC1=NC(O)=NC(O)=N1 ZFSLODLOARCGLH-UHFFFAOYSA-N 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001786 isothiazolyl group Chemical group 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 230000008818 liver damage Effects 0.000 description 1
- 230000002535 lyotropic effect Effects 0.000 description 1
- 150000002678 macrocyclic compounds Chemical class 0.000 description 1
- 239000008204 material by function Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000010907 mechanical stirring Methods 0.000 description 1
- JDSHMPZPIAZGSV-UHFFFAOYSA-N melamine Chemical compound NC1=NC(N)=NC(N)=N1 JDSHMPZPIAZGSV-UHFFFAOYSA-N 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- AYLRODJJLADBOB-QMMMGPOBSA-N methyl (2s)-2,6-diisocyanatohexanoate Chemical compound COC(=O)[C@@H](N=C=O)CCCCN=C=O AYLRODJJLADBOB-QMMMGPOBSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 210000001724 microfibril Anatomy 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000002159 nanocrystal Substances 0.000 description 1
- 229960002009 naproxen Drugs 0.000 description 1
- CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical compound C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 description 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 235000015205 orange juice Nutrition 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 150000002924 oxiranes Chemical class 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 229960001173 oxybenzone Drugs 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000011236 particulate material Substances 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- PCIUEQPBYFRTEM-UHFFFAOYSA-N perfluorodecanoic acid Chemical compound OC(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F PCIUEQPBYFRTEM-UHFFFAOYSA-N 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000012450 pharmaceutical intermediate Substances 0.000 description 1
- 125000001828 phenalenyl group Chemical group C1(C=CC2=CC=CC3=CC=CC1=C23)* 0.000 description 1
- 125000001792 phenanthrenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3C=CC12)* 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 150000003003 phosphines Chemical class 0.000 description 1
- 238000006552 photochemical reaction Methods 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 238000000678 plasma activation Methods 0.000 description 1
- 229920001485 poly(butyl acrylate) polymer Polymers 0.000 description 1
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920000447 polyanionic polymer Polymers 0.000 description 1
- 229920002577 polybenzoxazole Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 150000003071 polychlorinated biphenyls Chemical class 0.000 description 1
- 125000003367 polycyclic group Chemical group 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920006393 polyether sulfone Polymers 0.000 description 1
- 229920005594 polymer fiber Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000012254 powdered material Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000011085 pressure filtration Methods 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 125000001725 pyrenyl group Chemical group 0.000 description 1
- 125000002098 pyridazinyl group Chemical group 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 125000005551 pyridylene group Chemical group 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 238000000197 pyrolysis Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- JWVCLYRUEFBMGU-UHFFFAOYSA-N quinazoline Chemical compound N1=CN=CC2=CC=CC=C21 JWVCLYRUEFBMGU-UHFFFAOYSA-N 0.000 description 1
- 125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 description 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 1
- 125000005493 quinolyl group Chemical group 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 239000013557 residual solvent Substances 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 239000005060 rubber Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- FZHAPNGMFPVSLP-UHFFFAOYSA-N silanamine Chemical compound [SiH3]N FZHAPNGMFPVSLP-UHFFFAOYSA-N 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910052814 silicon oxide Inorganic materials 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 229940006186 sodium polystyrene sulfonate Drugs 0.000 description 1
- 239000011122 softwood Substances 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 239000012265 solid product Substances 0.000 description 1
- 238000002470 solid-phase micro-extraction Methods 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 239000012798 spherical particle Substances 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 229960005404 sulfamethoxazole Drugs 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- JLKIGFTWXXRPMT-UHFFFAOYSA-N sulphamethoxazole Chemical compound O1C(C)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 JLKIGFTWXXRPMT-UHFFFAOYSA-N 0.000 description 1
- 238000004808 supercritical fluid chromatography Methods 0.000 description 1
- 239000002352 surface water Substances 0.000 description 1
- 238000010301 surface-oxidation reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- UGNWTBMOAKPKBL-UHFFFAOYSA-N tetrachloro-1,4-benzoquinone Chemical compound ClC1=C(Cl)C(=O)C(Cl)=C(Cl)C1=O UGNWTBMOAKPKBL-UHFFFAOYSA-N 0.000 description 1
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- 125000001113 thiadiazolyl group Chemical group 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 230000001550 time effect Effects 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- IAQRGUVFOMOMEM-ONEGZZNKSA-N trans-but-2-ene Chemical compound C\C=C\C IAQRGUVFOMOMEM-ONEGZZNKSA-N 0.000 description 1
- 150000003852 triazoles Chemical class 0.000 description 1
- 125000001425 triazolyl group Chemical group 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- JFALSRSLKYAFGM-UHFFFAOYSA-N uranium(0) Chemical compound [U] JFALSRSLKYAFGM-UHFFFAOYSA-N 0.000 description 1
- 150000003672 ureas Chemical class 0.000 description 1
- 238000011179 visual inspection Methods 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 238000001238 wet grinding Methods 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D53/00—Separation of gases or vapours; Recovering vapours of volatile solvents from gases; Chemical or biological purification of waste gases, e.g. engine exhaust gases, smoke, fumes, flue gases, aerosols
- B01D53/02—Separation of gases or vapours; Recovering vapours of volatile solvents from gases; Chemical or biological purification of waste gases, e.g. engine exhaust gases, smoke, fumes, flue gases, aerosols by adsorption, e.g. preparative gas chromatography
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/22—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material
- B01J20/24—Naturally occurring macromolecular compounds, e.g. humic acids or their derivatives
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/22—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material
- B01J20/26—Synthetic macromolecular compounds
- B01J20/265—Synthetic macromolecular compounds modified or post-treated polymers
- B01J20/267—Cross-linked polymers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/28—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties
- B01J20/28054—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties characterised by their surface properties or porosity
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/28—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties
- B01J20/28054—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties characterised by their surface properties or porosity
- B01J20/28057—Surface area, e.g. B.E.T specific surface area
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/28—Treatment of water, waste water, or sewage by sorption
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/28—Treatment of water, waste water, or sewage by sorption
- C02F1/283—Treatment of water, waste water, or sewage by sorption using coal, charred products, or inorganic mixtures containing them
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/28—Treatment of water, waste water, or sewage by sorption
- C02F1/285—Treatment of water, waste water, or sewage by sorption using synthetic organic sorbents
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/28—Treatment of water, waste water, or sewage by sorption
- C02F1/286—Treatment of water, waste water, or sewage by sorption using natural organic sorbents or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/28—Treatment of water, waste water, or sewage by sorption
- C02F1/288—Treatment of water, waste water, or sewage by sorption using composite sorbents, e.g. coated, impregnated, multi-layered
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2101/00—Nature of the contaminant
- C02F2101/10—Inorganic compounds
- C02F2101/20—Heavy metals or heavy metal compounds
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2101/00—Nature of the contaminant
- C02F2101/30—Organic compounds
- C02F2101/308—Dyes; Colorants; Fluorescent agents
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2101/00—Nature of the contaminant
- C02F2101/30—Organic compounds
- C02F2101/36—Organic compounds containing halogen
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2103/00—Nature of the water, waste water, sewage or sludge to be treated
- C02F2103/06—Contaminated groundwater or leachate
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2303/00—Specific treatment goals
- C02F2303/04—Disinfection
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B15/00—Preparation of other cellulose derivatives or modified cellulose, e.g. complexes
- C08B15/10—Crosslinking of cellulose
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B31/00—Preparation of derivatives of starch
- C08B31/003—Crosslinking of starch
- C08B31/006—Crosslinking of derivatives of starch
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
- C08G18/30—Low-molecular-weight compounds
- C08G18/302—Water
- C08G18/305—Water creating amino end groups
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
- C08G18/40—High-molecular-weight compounds
- C08G18/64—Macromolecular compounds not provided for by groups C08G18/42 - C08G18/63
- C08G18/6484—Polysaccharides and derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/70—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the isocyanates or isothiocyanates used
- C08G18/72—Polyisocyanates or polyisothiocyanates
- C08G18/74—Polyisocyanates or polyisothiocyanates cyclic
- C08G18/76—Polyisocyanates or polyisothiocyanates cyclic aromatic
- C08G18/7614—Polyisocyanates or polyisothiocyanates cyclic aromatic containing only one aromatic ring
- C08G18/7621—Polyisocyanates or polyisothiocyanates cyclic aromatic containing only one aromatic ring being toluene diisocyanate including isomer mixtures
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/70—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the isocyanates or isothiocyanates used
- C08G18/72—Polyisocyanates or polyisothiocyanates
- C08G18/74—Polyisocyanates or polyisothiocyanates cyclic
- C08G18/76—Polyisocyanates or polyisothiocyanates cyclic aromatic
- C08G18/7657—Polyisocyanates or polyisothiocyanates cyclic aromatic containing two or more aromatic rings
- C08G18/7664—Polyisocyanates or polyisothiocyanates cyclic aromatic containing two or more aromatic rings containing alkylene polyphenyl groups
- C08G18/7671—Polyisocyanates or polyisothiocyanates cyclic aromatic containing two or more aromatic rings containing alkylene polyphenyl groups containing only one alkylene bisphenyl group
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2305/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
- C08J2305/16—Cyclodextrin; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J9/00—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
- C08J9/0014—Use of organic additives
- C08J9/0028—Use of organic additives containing nitrogen
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L5/16—Cyclodextrin; Derivatives thereof
Abstract
The present disclosure relates to a porous polymeric material comprising a plurality of cyclodextrins covalently crosslinked with a plurality of crosslinks of formula (I) as shown in the abstract drawing and a counteranion (X-), as well as related methods of purifying a fluid sample, and related solid-phase extraction devices.
Description
CHARGE—BEAEMNG CYCLGDEXTRlN PGL‘thERlC h/lATERlALS AND h/lli'l‘lrlGDS 0F hlAKlNG AND USlNG SAhllij mmnmunmm {twill} Organic niicropollutants (MPs) are present in water resources at ng L"1 to pg L—1 concentrations as a uence of human activitiesl’2 Concerns about their negative effects on human health3"7 and the environmentg‘m motivate the development of technologies that remove lvll?’s more effectively."16 MPs span a wide variety of cheniical properties including surface charge, size, and chemical functionality. Charged Ml’s can he cationic, c, or zwitterionic and are typically difficult to remove in the ce of complex matrix constituents like natural organic matter (NOM) using conventional adsorption methods like activated carbon.
Of the anionic h/lPs, PFASs present a particular nmental prohleni because of their resistance to hiodegradation and correlation to negative health s. PFASs have been used in the formulations of thousands of consumer goodsl and are present in aqueous foam formulations used to ss on fires in training scenarios. ""9 As a result, they have contaminated surface and ground waters near thousands of airports and, military installations.20 ln 2016, Hu and coworkers showed that at least 6 million Americans were served drinking water contaminated with PFASS at or above the US EPAs 20l6 health advisory limit for pertluorooctanoic acid (PFOA) and pertluorooctanesulfonic acid (PFOS) of 70 ng liil.21 PFASs have been linked to cancers,3 liver damage,4 thyroid disease5 and other health problems.6 {lllll‘tZ} Contaminated water systems are typically iated with granular activated carbon (GAG), but its modest affinity for PFASS, particularly short chain tives, makes it an ive and stop~gap solution."24 in recent reports, 14’13 it was discovered that noncovalent interactions and the electrostatics of functional groups influence PFAS affinity to adsorbents, For example, a combination of fluorophilic interactions of the crosslinlter and a lower concentration of anionic charged functional groups in uorohiphenyldinlred CDPs led to high PFOA and PFOS removal from water. in contrast, CDPs crosslinked by epichlorohydrin exhibited inferior FFAS removal.25 {(3893} Adsorption processes can be employed to remove specific inants or contaminant classes from fl uids like air and water. Activated carbons (A (Is) are the most widespread sorhents used to remove organic ants, and their efficacy derives ily from their high surface areas, nanostructured pores, and hydrophobicity. However, no single type ofAC removes all contaminants well, particularly anionic h/ll’s. Because of their poorly defined structure and binding site ion, optimal adsorption selectivities e empirical screening at new installations, precluding rational design and, improvement. Furthermore, regenerating spent AC is energy intensive (heating to Siltlngt‘it‘i" C or other energy intensive procedures) and does not restore full performance. AC also has a slow pollutant uptake rate, achieving its uptake equilibrium in hours to days, such that more rapid contaminant removal requires excess sorbent.
Finally, AC can m poorly for many ng contaminants, particularly those that are relatively hydrophilic.
{Wild} An alternative adsorbent material can he made from polymeric cyclodextrin materials ed from insoluble polymers of B—cyclodextrin (B—CD), which are toroidal macrocyeles comprised of seven glucose units whose internal cavities are capable of binding organic compounds. Ei—CD is an inexpensive and sustainably produced monomer derived from cornstarch that is used extensively to formulate and stabilize pharmaceuticals, flavorants, and fragrances, as well as within chiral chromatography stationary phases. lnsoluhle ?—CD polymers have been formed by crosslinlsing with epichlorohydrin and other reactive compounds, and feature well d binding sites and high association constants, hle Ei—CD polymers crosslirtked with epichlorohydrin have been investigated as alternatives to AC for water purification, hut their low surface areas result in interior sorhent mance relative to ACs. {(3895} Thus there is a need for new sorbents that address the deficiencies ofAC and the like and which will e more effective sorption and/or sequestration properties for MPs (such as anionic MPs). Th ere is a need for an adsorbent that provides rapid anionic MP extraction, high total uptake, and facile regeneration and reuse procedures. This ion meets those needs, Summary {dildo} in some embodiments, the present disclosure es a porous polymeric material comprising a plurality of cyclodextrins crosslinlred with a plurality of crosslinlss comprising formula (l): wherein A is an aiyl or neteioaryl nieiety; each R1 is. independently selected from the group cdnsisting ofH C1—C6 alkyl, C1—C3 halnalkyh aryl, lietei‘daiyl? ~CF3, —SOiH, —CN, "N02, ~NH2 ~NCO? ~C(O)2R3, —C(O)N(R3)2, and — halogen; each R2 is independently H, —0H, —O~nietai cation, al,kyl., aryi, netematyl, ~SH? —S—nietal catidn, —S~aikyl, "C(OhH, er ~C(O)NH2; each R3 is. independently —H, —C1'C6 allay}? —C1'C3 liyi, —atyle —C(O)N(Ra)(Rb), —C(O)R", —C02RC, —SOzN(R"‘)(RbL or —SOR‘, and each Ra and Rb is ndently H or C1—C6 alkyl. each W is independently a, bond, an alkylene group, an arylene greup, a hetemarylene gmup, lene-, ~(Cl-{23a—aiylene—, —SO2—erylene~, ~Nlri-erylene~, ~S—aiyletie—, —O~ neteioeiylene-, ~(Cl-{23a—hetemaryleneg —SQ2—heteraeen/letie-, —NH-l’ieteroeiylene-, ~S— AK J-k N 0""(CHzla‘Z‘ neteieeiylene-, ---(---O»—--(CH2)a—--)x---, ---t---NH—--(Cl-12)) -—S»—-—(Ci—igi), , c c H N—utcnzni' _ . or H H n a 15 0-100 and x. is. l—lOtl, and each aryiene 0t heteroai’ylene tneiety can be substituted or unsubstituted; each Z is a, eatieiue moiety or an anionic moiety; each L is independently a linking moiety selected from the group consisting of MO -—S-—- —N—, C1-C6 substituted or unsubstituted ne, C1—C3 lialoalkyleiie, O Q O C} O 8 . O G AK JLx /* A'\, [J‘K /* /L\ X ? 0 G E RAG/‘2‘ A\O/U\*, {i .Jk A A a a and E g a 7 3 7 , A’ is a covalent bond to A; Z’ is a covalent bond; to Z; * is a covalent bond to g; ‘3 is a point of attachment to the plurality of cyclodextrin carbon atoms; X is GUS; y: is lnzflj, yz is lull; and ys is 04.
{NEW} in some embodiments, the crosslinks of the porous polymeric al comprise formula (ll): wherein yz is l or 2; and X is l or 2. {titlllS} in some embodiments, the porous polymeric material of the present disclosure comprises a plurality of linkers of formula (ill); %) H H N N .. . 0%?!" R4 ' R4 03 (iii) wherein one R4 is ---l-l and one R4 is v--—Me.
{M1399} in some embodiments, the present disclosure provides a supported porous polymeric material comprising porous particles affixed to a solid substrate, wherein said porous particles comprise a plurality of cyclodextrin moieties with a plurality of crosslinks comprising formula (u (in, or out {Wild} in some embodiments, the present disclosure provides a method of purifying a fluid sample comprising one or more pollutants, the method comprising contacting the fluid sample with the porous polymeric material or the ted porous polymeric material of the present disclosure whereby at least 50 wt. % of the total amount of the one or more pollutants in the fluid sample is adsorbed by the porous polymeric material. lilllllll ln some embodiments, the present disclosure provides a method of removing one or more compounds from a fluid sample or determining the presence or e of one or more nds in a fluid sample comprising: a) contacting the sample with the porous polymeric material or the supported porous polymeric material of the present disclosure for an incubation period; b) separating the porous polymeric material or supported porous polymeric material after the incubation period from the sample; and c) heating the porous polymeric material or supported porous polymeric al separated in step b), or contacting the porous polymeric material or supported porous polymeric material ted in step b) with a. solvent, thereby releasing at least a portion of the compounds from the porous ric al or supported porous polymeric al; and d l) optionally isolating at least a portion of the compounds released in step c); or d2) ining the presence or absence of the nds released in step c} wherein the presence of one or more compounds ates to the presence of the one or more compounds in the sample. {@912} ln some embodiments, the t disclosure provides an article of manufacture comprising the porous polymeric material or the supported porous polymeric material of the present disclosure escrl tion of the Brawin s {Wlft} Fig. l shows a comparison of PFAS uptalre capability of rs of the present disclosure at 0.5 hours (top) and 48 hours (bottom).
{WM} Fig. 2 shows a comparison between two choline chloride—modified 'l‘FNuCDF polymers and a {3—CD—l‘Dl polymer for PFOA uptalre (top) and PFGS uptake (bottoni). {8815} Fig. 3 shows a 1H NMR spectrum for B—(iD—TDl polymer (top) and fluCD (bottom).
{W16} Fig. 4 shows the change in the 1H NMR spectrum of fiatCDu'l‘Dl polymer upon addition {W17} Fig. 5 shows a comparison of various BuCD~'l"l)l polymers made with different p— CDYFDE molar equivalents.
{W18} Fig. 6 shows a comparison of choline chloride—modified BuCD—E‘Dl rs made with different molar equivalents of e de.
{W19} Fig. 7 shows choline—chloride modified FN uptake studies performed with methylene blue (top) and methyl orange (bottom).
{W20} Fig. 8 shows MO uptake isotherms for modified 'l‘FNucDF polymers with l5 (top) and 3.0 (middle) equivalents of choline chloride, and unmodified 'l‘F‘NuCDF (bottom). Dots represent the experimental data points and straight lines are the fitted curves using a ir model. {8821} Fig. 9 shows EPA uptake isotherms for modified 'l‘FNuCDF polymers with l5 (top) and 3.0 (middle) equivalents of choline chloride, and unmodified ’lFN~CDl’ (bottom). Dots represent the experimental data points and straight lines are the fitted curves using a Langmuir model.
{W22} Fig. l0 shows a 1H NMR spectrum of a choline chloride—modified fluCD—TDE polymer made with l:6:l molar equivalents of ?—CD:TDl:choline chloride.
{W23} Fig. ll shows a ison of a choline chlorideumodified ButjDu'l‘Dl polymer and a ll" CDJI‘Dl polynier.
{W24} Fig. l2 shows a comparison n three e chloride—modified p—(ID—TDl polymers with different choline chloride loading amounts.
{W25} Fig. l3 shows FFOA uptake of choline chloride—modified fi—CD—TDI polymers. {9926} All documents cited herein are incorporated by nce in their entirety for all es to the same extent as if each individual document was specifically and individually indicated to be orated by reference. {(130327} As used above, and throughout this disclosure, the following terms, unless otherwise indicated, shall be understood to have the following meanings. If a term is missing, the conventional term as lrnown to one slrilled in the art controls. {9928} As used herein, the terms "including," "containing," and "comprising" are used in their open, nonmliniiting sense. {8829} The articles "a" and "an" are used in this disclosure to refer to one or more than one t: 1'.c to at least one) of the grammatical obj ect of the article. By way of example, "an element" means one element or more than one element. {(130330} The term "and/or" is used in this disclosure to mean either "and" or "or" unless indicated otherwise. {(130331} To provide a more concise description, some of the tative expressions given herein are not qualified with the term "about". lt is understood that, whether the term " is used explicitly or not, every quantity given herein is meant to refer to the actual given value, and it is also meant to refer to the imation to such given value that would reasonably be inferred based on the ry slrill in the art, including equivalents and imations due to the experimental and/or measurement conditions for such given value. Whenever a yield, is given as a percentage, such yield refers to a mass of the entity for which the yield is given with respect to the maximum amount of the same entity that could he obtained under the particular stoichioinetric conditions. Concentrations that are given as percentages refer to mass ratios, unless indicated differently. {(3932} The term, adsorbent or adsorh is used to refer to compositions or methods of the present disclosure to refer to solid materials as described herein which remove contaminants or pollutants, typically but not exclusively organic molecules, from a fluid medium such as a. liquid (eg, water) or a gas (eg, air or other commercially useful gases such as nitrogen, argon, helium, carbon dioxide, anesthesia gases, etc). Such terrns do not imply any specific physical mechanism (e.g adsorption vs. absorption). {8833} The term "cyclodextrin" includes any of the lrnown cyclotlextrins such as unsubstituted cyclodextrins containing from six to twelve glucose units, especially, cyclodextrin, beta~ cyclodextrin, gamniaucyclodextrin and/or their derivatives and/or mixtures thereof. The alpha— cyclodextrin consists of six glucose units, the hetaucyclodextrin consists of seven glucose units, and the gamma—cyclodextrin consists of eight glucose units arranged in donut-shaped rings. The ic coupling and conformation of the glucose units give the cyclodextrins rigid, conical lar structures with hollow interiors of specific volumes. The "lining" of each internal cavity is formed by hydrogen atoms and glycosidic bridging oxygen atoms, therefore, this e is fairly hydrophobic. The unique shape and physicalnchernical properties of the cavity enable the cyclodextrin molecules to ahsorb (form inclusion complexes with) organic molecules or parts of organic molecules which can fit into the cavity. {0934} Unless otherwise stated, the terms "crosslinlrer" or "crosslinlr" or "linker" refer to a monomer capable of reacting with or forming a covalent linkage between one or more cyclodextrins or polymers, For example, if the crosslinher reacts at the end of a polymer chain, it may covalently react with one cyclodextrin moiety of the polymer (eg. via the glycosiilic oxygen of the cyclocl extrin), The crosslinlrer may or may not, further react with other monomers or cyclorlextrin units or r chains to, for example, extend a polymer chain or link two or more r chains together, For example the crosslinker may he hound to l, 2, 3, or 4+ monomers or cyclodextrin units or rs, {9935} The term nic moiety" refers to a group which carries a positive charge (eg, +l +2, etc), for example, ammonium, mono~, di— or triallrylamrnonium, diallrylsulfonium and triallrylphosphonium, {9936} The term "anionic moiety" refers to a group which carries a ve charge (eg —l , ~2, etc), for example, phosphate, carhoxylate, alkoxide, and sulfate. {(3937} As used herein, "alkyl" means a straight chain or branched saturated chain having from 1 to ill carbon atoms. Representative saturated alkyl groups include, but are not limited to, methyl, ethyl, n-propyl, isopropyl, Z-niethyl-l l, 2-methyl~2-propyl, yl~l ~hutyl, 3— methyl—l—hutyl, 2-methyl~3~hutyl, 2,2-dimethyld ~propyl, 2~inethyl—l l, 3-methyl~l ~pentyl, llamethylulupentyl, Emmethyl—Zupentyl, 3—inethyl~2—pentyl, 4uniethyl—2uperi'tyl, 2,2—dimethyl—l_ hutyl, methylulubutyl, Zuetliyl—l—butyl, hutyl, isobutyl, t—hutyl, n—pentyl, isopentyl, neopentyl, n—hexyl and the like, and longer alkyl groups, such as lieptyl, and oetyl and the like.
An allryl group can be tituted or substituted. Allryl groups containing three or more carbon atoms may be ht, or ed. As used herein, "lower alhyl" means an alkyl having from l to 6 carbon atoms.
{Wild} The term "alkylene" refers to straight~ and branched~chain alltylene groups. Typical alkylene groups include, for example, methylene ("CHz—L ethylene ("Cl'elzCHM , propylene (~ CH2CH2CH2-) n— hutylene (—CHzCH2CH2CH2n) , isopropylene ("CHtZCH?CHH , , seo~butylene (—CH(CH2CH3)CH2U) and the like. {9&39} The term "hydroxyl" or "hydroxy" means an OH group; {9949} It should also he noted that any carbon as well as heteroatorn with unsatisfied valences in the text, schemes, examples and Tables herein is assumed to have the sufficient number of hydrogen atom(s) to satisfy the yalenees. {hilt-ll} The term "halo" or "halogen" refers to fluorine, chlorine, bromine, or iodine. {9942} The term "oyano" as used herein means a substituent having a carbon atom joined to a nitrogen atom by a triple bond, in, GEN. {@943} The term "amine" or "amino" as used herein means a substituent containing at least one nitrogen atom. Specifically, NH; —NH(allryl) or all ainide, urea, and sulfarnide suhstituents are included, in the term "aniino". {tilled} Unless otherwise specifically defined, the term "aryl" refers to cyolio, aromatic hydrocarbon groups that have l to 3 aromatic rings, including monooyelic or hicyclic groups such as , biphenyl or naphthyl. Where containing two aromatic rings (bioyelic, eta), the ic rings of the aryl group may be joined at a single point (eg, yl), or fused (gig, naplithyl). Furthermore, in the context of the t disclosure, the term aryl is taken to refer to two aryl rings joined by a short linker suelt as —CH2—, CR2— (where R can be H, alltyl, etc), 4302—, —SO~, ~NR— (where R can be H, alkyl, etc), or —O—; for example, aryl may refer to methylene diphenyl or oxybisphenyl tively). The aryl group may be ally substituted by one or more substituents, eg, l to 5 substituents, at any point of attachment. The substituents can themselves be optionally substituted. Furtherinere when containing twe fused rings the aryl groups herein d may have an unsaturated er partially saturated ring fused with a fully saturated ring. Exemplary ring systems all these aryl groups include, hut are net limited to, , yl, naphthyl, anthraeenyl, phenalenyl, phenanthrenyl, indanyl, indenyl, tetrahydrenaphthalenyl, tetrahydrobenzeannulenyl, and the like. {8345} Unless ise specifically defined, "heternaryl" means a nionoyalent nioneeyclie er polycyclic aromatic radical nf 5 to 18 ring atoms or a polycyclic aromatic radical, containing one or more ring hetereaterns selected, from N, 0, er S, the remaining ring atonis being C.
Heterearyl as herein defined also means a polycyclic (eg, hieyclic) heternaromatic group wherein the heternatorn is selected from N, O, or S. The ic radical is optionally substituted independently with one or more substituents descrihed herein. The suhstituents can themselves be ally tuted. es include, but are not limited to, benzethiophene, furyl, thienyl, pyrrelyl, pyridyl, pyrazinyl, pyrazelyl, pyridazinyl, pyrimidinyl, iinidazelyl, isexazelyl, exazelyL exadiazolyl, nyl, indnlyl, tliieplieri~2~yl? quinelyl, henzepyranyl, isothiazolyl, thiazolyl, thiadiazolyl, thieneEfi,2—blthinphene? triazelyl, triazinyl, imidazo? ,2- zelyl, furan?~clpyridinyl? iniidazo? ,2malpyridinyl, in,daznlyl., pyrrolo??—e]pyridinyl, pyrrolo?,2melpyridinyl, le[3,4~e]pyridinyl, henzeimidazelyl, thi,eno{3.,2—tt]pyridinyl, thienan?~c}pyridinyl., thiene??~blpyridinyl, henzethiazolyl, indolyl, indolinyl, indolinonyl, dihydrobenzethiophenyl, nbenzefuranyl, benzoi’uran, nyl, thinehromanyl, tetrahydrnquinulinyl, nbenzothiazine, dihydrohenzoxanyl, quinolinyl, ianmnolmyl? if» napl'ithyridinyl, henmlde}isequinolmyl, pyridoEd?hHl ?lnaphthyridmyl, thieneQ?l3h3yrazinyl , quinazolinyl, tetramlell,5~a}pyridinyl, [l riazololél?—a]pyridinyl, isoindolylg pyrrelo??—h}pyridinyl, pyrrolo?,4—hlpyridinyl, pyrrolo?Q—blpyridinyl, imidaznlfi,4~ hlpyridinyl, pyrrololl ,Z—alpyrimidinyl, tetrahydropyrrololl ,Z—alpyrimidinyl, 3,4—dihydrn—ZH~ lAZ-pyrrelopgl—hlpyrirnidme? dihenzeEh?}thiophene, pyridirnzone, furol3,Z—cjpyridinyl, l‘urelZ?nelpyridmyl, illupyridQESAuhjlLilithiazmyl, henzeexazelyl, henzeisexazelyl, furan?— hjpyridinyl, benzothiephenyl, l,5—naphthyridinyl, fure[3,2—hlpyridine, 4}triazele{l,5~ ailpyridinyl, henzo [1,2,3]triazolyl, irnidazoll,Zualpyrimidinyl, {l,2,4:Etriazele{4,3—hjpyridazinyl, benzele] { l ,2,5 lthiadiazolyl, henzole}{1,2,5}oxadiazele, l ,3 —dihydrta—2ll~lien;:ta{idliniidazolu?one 3,4—dihydro—Zl-lupyrazolol:l ,Sub} [: l ,2] exazinyl, 4,5,6,7_tetrahydropy razeloll ,S—alpyridinyl, thiazelel5,4—djthiazolyl, iniidazole?uhlll ,3,4:§thiadiazelyl, thierio[2,3— jpyrrelyl, 3l-luindolyl, and derivatives thereof. Furthermore when containing two fused rings the heteroaryl groups herein defined may have an rated or lly saturated ring fused with a fully saturated ring. {8346} Numerical ranges, as used , are ed to include sequential integers unless indicated otherwise. For example, a range expressed as "from O to 5" would e 0, l, 2, 3, 4 and 5. {8847} The present sure provides porous t: e. g. niicroporous or mesoporous), typically high surface area cyclodextrin polymeric materials (PuCDPs), as well as methods of making and using these materials. The P—CDPs are comprised of insoluble polymers of cyclodextrin, which is an inexpensive, nably produced macrocycle of glucose. The cyclodextrin polymers are inked with linking groups as described herein. The polymers of cyclodextrin are comprised of cyclodextrin moieties that are derived from cyclodextrins. The cyclodextrin nioiety'(s) can he derived from naturally occurring cyclodextrins (eg, Cir, 33-, and 7—, comprising 6, 7, and 8 glucose units, respectively) or synthetic cyclodextrins. The cyclodextrin moiety has at least one —0— bond derived from an —OH group on the cyclodextrin from which it is derived.
The cyclodextrin moieties can comprise 3—20 glucose units, including 3, 4, 5, 6, ‘7, 8, 9, l0, ll, l2, l3, l4, l5, l6, l7, 18, l9, and 20 glucose units, inclusive of all ranges therehetween, In, many embodiments, the cyclodextrin moieties are derived from starch, and comprise 6—9 glucose units, The polymeric materials may comprise two or more different cyclodextrin moieties. ln particular embodiments, the P—CDP is comprised of insoluble polymers of ll~cyclodextrin (BED), lull/43} The P—CDP can also comprise cyclodextrin derivatives or modified extrins, The derivatives of cyclodextrin consist mainly of molecules wherein some of the OH groups are converted to OR groups, The cyclodextrin derivatives can, for example, have one or more additional moieties that provide additional functionality, such as desirable solubility behavior and ty characteristics, Examples of suitable cyclodextrin derivative materials e methylated cyclodextrins (eg, RAMEB, randomly methylated ll—cyclodextriris), hydroxyalkylated cyclodextrins (e, g, hydroxypropyl—ll—cyclodextrin and hydroxypropyl—y— cyclodextrin), acetylated cyelodextrins (e, g, acetyl—y—cyclodextrin), reactive extrins (eg, chlorotriaziriyh{tCD}, branched cyclodextriris (eg, glucosyl~B~cyelodextrin and maltosyl-?— cyclodextrin), utyl—ll—cyclodextrin, and sulfated cyclodextrins. For example, the cyclodextrin nioiety further comprises a moiety that binds (eg, with specificity) a metal such as arsenic, cadrhium, copper, or lead. {111149} The P—CDP can also comprise cyclodextrin derivatives as disclosed in US Pat. No. 6,881,712 including, e.g., cyclodextrin tives with short chain alkyl groups such as methylated cyclodextrihs, and ethylated cyclodextrihs, wherein R is a methyl or an ethyl group; those with hy droxyalhyl substituted groups, such as hydroxypropyl cyclodextrihs and/or hydroxyethyl cyclodextrins, wherein R is a —CH2—CH{OH)—CF13 or a "CH2CHz—0H group; branched cyclodextrins such as inaltose—honded cyclodextrins; ic cyclodextrins such as those ning 2—hydroxyn3n(dimethylarnino)propyl ether, wherein R is CH2—CH(OH)— CH3)2W’thl’l is cationic at low pH; quaternary ammonium, e.g, 2nhydroxy—3~ (trinrethylannnonio)propyl ether chloride , wherein R is CH2—CH(OH)—CH22— Cl"; anionic cyclodextrins such as carboxyniethyl cyclodextrins, cyclodextrin sulfates, and cyclodextrin succinylates; ainphoteric cyclodextrins such as carhoxyniethyl/quaternary ammonium cyclodextrins; cyclodextrins wherein at least one glucopyranose unit has a 3—6— o—cyclonialto structure, eg, the mono~3~6~anhydrocyclodextrins, as disclosed in al Performances with Minimal Chemical Modi?cation of Cyclodextriris", 1:7. nivPilard and B, Perly, The 7th International Cyclodextrin Symposium Abstracts, April 1994, p, 49 said references being incorporated herein by reference; and mixtures thereof. Other cyclodextrin derivatives are disclosed in US. Pat. No. 3,426,011, Parnierter et a1, issued Fe‘o~ 4, 1969; US Pat. Nos. 3,453,257; 3,453,258; 3,453,259; and 3,453,260, all in the names ot‘l’arnierter et al, and all issued Jul. 1, 1969; US. Pat. No. 3,459,731, Gramera et al, issued Aug. 5, 1969; US. Pat, No. 3,553,191, Parrnerter eta1., issued Jan. 5, 1971; US. Pat. No. 887, Parrnerter et al, issued Feb, 23, 1971; US. Pat. No, 4,535,152, Szeitli et a1, issued Aug~ 13, 1985; US Pat. No~ 4,616,008, Hirai et al, issued Oct. 7, 1986', US. Pat. No, 598, Ogino eta1., issued Jul. 7, 1987; US. Pat. No. 4,638,058, Brandt et a1, issued Jan 20, 1987; and US Pat. No~ 4,746,734, 'l‘sucliiyania et a1, issued May 24, 1988, all of said patents heing incorporated herein hy reference. {1111511} In some embodiments, the present sure provides a porous polymeric material comprising a plurality of cyclodextrins crossliiil formula (:1): wherein A is an aiyl or neteioaryl nieiety; each R1 is. independently selected from the group cdnsisting ofH C1—C6 alkyl, C1—C3 halnalkyh aryl, lietei‘daiyl? ~CF3, —SOiH, —CN, "N02, ~NH2 ~NCO? ~C(O)2R3, —C(O)N(R3)2, and — halogen; each R2 is independently H, —0H, —O~nietai cation, al,kyl., aryi, netematyl, ~SH? —S—nietal , —S~aikyl, "C(OhH, er ~C(O)NH2; each R3 is. independently —H, —C1'C6 allay}? —C1'C3 haloalliyi, —atyle —C(O)N(Ra)(Rb), —C(O)R", —C02RC, —SOzN(R"‘)(RbL or —SOR‘, and each Ra and Rb is independently H or C1—C6 alkyl. each W is independently a, bond, an ne group, an arylene greup, a hetemarylene gmup, lene-, ~(Cl-{23a—aiylene—, —SO2—erylene~, erylene~, ~S—aiyletie—, —O~ neteioeiylene-, ~(Cl-{23a—hetemaryleneg —SQ2—heteraeen/letie-, —NH-l’ieteroeiylene-, ~S— AK J-k N 0""(CHzla‘Z‘ neteieeiylene-, ---(---O»—--(CH2)a—--)x---, ---t---NH—--(Cl-12)) »---(»-—S»—-—(Ci—igi), , c c H A.\N/LN—utcnzni' _ . or H H wherein a 15 0-100 and x. is. l—lOtl, and each aryiene 0t heteroai’ylene tneiety can be tuted or unsubstituted; each Z is a, ue moiety or an anionic moiety; each L is independently a linking moiety selected from the group ting 015me -—S-—-, A'\ /u\ /* —N—, C1-C6 substituted or unsubstituted alkylene, C1—C3 baloalkylene, O Q O C} a a: 0 AFN" /* Al\, /* O d , J Gsia sis: i a MA ii: i i i , we A’ is a covalent bond to A; Z’ is a covalent bond to Z; * is a covalent bond to g; ‘3 is a point of attachment to the plurality of cyclodextrin carbon atoms; X is GUS; yi is lnzflj, yz is lull, and y3 is Quail. illilSl} Each Z is a cationic moiety or an c moiety. For example, in some ments, each Z is a cationic . in certain ments, each cationic moiety is ndently — N(R3)3+, —l3‘(R3)3+, —S(R3)z+, oi~ —Hetei'oai'yl+ wherein each R3 is independently —H, —Ci-Cs alkyl, —CinC3 haloalkyl, —aiyl, —C(O)N(Ra)(Rb), —C(O)Rf, —C02Rc, —802N(Ra)(Rb), or —SORC, and each Ra and Rb is independently H, or Ci—Cs alkyl. For example, in some embodiments, each cationic moiety is —N(R3)3+ where each R3 is H or C1—C6 alkyl. Accordingly, in some embodiments, each cationic moiety is is —l**vl(l‘ide)3+ or is —NH3+, In some embodiments, eacli cationic moiety is is —N(Me)3+. in some embodiments, each cationic moiety is independently ~ Heteroaryll‘. A y of charged oaryls are contemplated in the context of the present disclosure and are readily apparent to a skilled artisan, For example, in some embodiments, — Heteroaryll' may refer to pyridininm, pyriolidininni, iinidazolium, triazolium, tetrazolium, and the like. in some embodiments, each Z is an anionic moiety. in certain embodiments, each p033 Ool""_/Ei,\ \\ O i Gui—Oioggigg0 li a; . . l . 9kg R3 anionic inciety is OR3 ,3 Q C) hi; or 7 9 a a 3 3 7 %_€>O ~ wherein each R3 is as defined above, i . {8852} ln accordance with certain embodiments of the present disclosure, each W is independently a bond, an allrylehe group (e g. 0, Gin—{720, or (in?rm), an arylene group, a heteroarylene group, uO—arylene—, 2)a—arylene~, —S()2_arylene—, uNl-l—aryleneu, lene_, ~ Ouheteroarylene—, )a~heteroarylene~, —S()2_heteraoarylene—, —Nl—luheteroarylene—, —S— heteroarylene—, ( G (CHM ). , ( NH (C?zh )a or , ( S (CHM ). whereinais 0—100 and X is l—lOO, and each arylene or heteroarylene moiety can be substituted or unsubstituted. The term ne" refers to a bivalent group derived from an aryl group (as described herein, including phenyl, hiphenyl, naphthyl, etc.) by removing hydrogen atoms from two ring carbons For example, an arylene can include a phenyl in which the two valencies are situated in an orthon or para- orientation. For polycyclic arylenes, the two valencies can be on the same ring, , meta: or on different rings. Arylenes can be derived from any ic rings described herein, and, can be substituted or tituted. Similarly, the term "beteroarylene" refers to a bivalent group derived from a heteroaryl group (as described herein, ing furyl, pyridyl, etc.) by removing hydrogen atoms from two ring atoms (whi ch can be carbon or heteroatoms). The valencies can be on the same ring or ditt‘erent rings (in the case of polycyclic heteroaromatics) and can be on any two ring atoms. arylenes can be d from any heteroaromatic rings described herein, and can be substituted or unsubstituted. Thus in some embodiments, each W is a bond (re, a covalent bond). In other embodiments, each W is an alliylene group. For example, each W may be, methylene {*CE‘IT‘), ethylene (—CllzCl-lz—) , propylene (~Cll2{:ll2(:ll2—) , isopropylene (—Cl?QCl-l?Cl-lr) n— butylene (—CHzCl-lgCl:lzCl-l2—) and the , , sec~butylene 2(Cl-l2Cl—ls)CH2—) like, in some embodiments, each ’W is methylene (—Cl—lr), ln some embodiments, each W is an arylene group (phenylene). in some embodiments, each W is a heteroarylene group {fury}, pyridyl). in some embodiments, each W is ~O—arylene— (-Q—phenylene), In some embodiments, each W is —(Cl5l2)a—arylene— (—Cliz—phenylene). in some embodiments, each W is —S{)2uaryleneu (~ SQzuplienylene). lh some embodiments, each W is ylene (—Nl—luphenylene). ln some embodiments, each W is —S~arylene~ (:uSuplienylene). lh some embodiments, each W is a hetei'oarylene group (furylene, pyridylene). in some embodiments, each W is ~0uheteroarylene— yridinylene:i. ln some embodiments, each W is —(Cl-lgh—heteroarylene— (—Cl-lz— pyridinylene}. ln some embodiments, each W is SOz—heteroarylehe— (—SQz—pyridinylene). in some embodiments, each W is uNl-l—heteroaryleneu (éNli—pyi‘idinylene). in some embodiments, each W is nS—heteroarylene~ ("S—pyridinylene). ln some embodiments, Wis —(O—CH2—CH2)x—.
. . \N/Ekomtmizla"? ln some embodiments, Wis --—O-—-~Cl-l2-—-Cl-l2-—-~._ _ _ , , in some embodiments, W is H where A" is a covalent bond to A and Z’ is a covalent bond to 2;. ln some emhcdimehts, Wis AKN/LLOAV, 2’ {(3853} In some embodiments, each instance of uW-Z is talten together to form ---O»---Cl-l'2---CHz—-- hel(R)3+~ In some embodiments, each instance of ---W»—--Z is talten together to form »-—O»---Cl-l2---Cl-lzm- NtMelf. lh some embodiments, each instance of --—-‘W—-—Z is taken together to form {<2 Omii N Me‘( )3 {@1954} In some emhodiments, each L is a linking moiety. ln some embodiments, each L is independently a linking moiety selected from the group ting ell-Om, -S-, --N»--, o o o it a Nhe» notN ?t it JL a ,, , i N N O O H H Ai 4:) O * H H and 7 7 :1 7 7 7 sNiNa 3‘ H H where A’ is a covalent bond to A and * is a covalent hand to 3 (which as descrihed herein represents a point of attachment to the plurality of cyclodextriri carbon atoms). In some embodiments, eacli L is independently "O"- ln n embodiments, when each L is Q A\N’Jl\O/k Q A'\ /U\ /* )L» I’ll independently O Q H AF 0 or --,--—O the oxygen atom maybe a , , glycosidic oxygen from the ity of cyclodextrins of the porous ric material or" the present disclosure. For example, in some embodiments, when each L is independently "0 the oxygen atom is a idic oxygen atom from the plurality of cyclodextrins of the porous polymeric material of the present sure. {9955} ln some embodiments, A is an aryl or heteroaryl moiety. in some embodiments, A is an aryl . For example, A may be phenyl, hiphenyl, naplithyl, anthracenyl, phehalenyl, phenantlireriyl, indanyl, indenyl, ydronaphthalehyl, or tetrahydrobenzoannulenyl. in some embodiments, A is a heterearyl moiety. For example, A may be benzethmphene, furyl, thieiiyl, pyrrelyl, pyridyl, pyrazmyl, lyl, pyridezinyl, pyrimidiriyl, imidazelyl, isoxazelyl, exazolyl, zelyl, pyreziiiyl, indelyl, thiephenuZuyl, quinolyl, benzopyranyl, isothiazelyl, thiazolyl, iazelyl, thiene{3,2~b}thi0phene, lyl, triazinyl, imidazell,Z—blpyrezelyl, furolZ?nelpyridmyl, o?,Z—alpyridinyl, indezolyl, lo{2,3—clpyridiiiyl, pyrrolol’??n clpyridinyl, pyramleBAnclpyridii‘iyl, benzeimidazolyl, tliienol’i,2nelpyridmyl, thienolZ?n idinyl, ll?nblpyridiiiyl, benzethiazelyl, indelyl, indolinyl, indoliiionyl, dihydrobenzethiophenyl, diliydi'ehenzofuranyl, benzofuran, chromanyl, thieehremanyl, tetrahyquuinelmyl, (lihydi'ebenzothiazme, dihydrobenzoxanyl, quiriolinyl, isequmolmyl, 1,6" iiaphthyridmyl, benzelde?sequmolmyl, pyridoH?—blll,6lnaplithyridmyl, thiene[2,3— blpyrazinyl, quinazolmyl, tetrazelell,SUaEpyridinyl, [l,2,4]triazolo[4,3"alpyridmyl, isomdolyl, ??~blpyridiiiyl, pyrmlolS,sil—bjpyridmyl, pyrrolo?,2—33}pyridinyl, imidazelidm blpyridinyl , pyrrel cl l ,Z—a}pyrimidinyl, tetrahydropyrrol0[ l ,Z—alpyrimldmyl , 3 ,4—diliydi‘0—2H~ lVapyrmlo?,l-bjpyrimidme, di,ben,zo[b,d}thiophene, n~2~one, furolS,2—ttlpyridiriyl, furo[2,3—c}pyridmyl, lH~pyrid0[3,4—b}{l ,d-lthiazmyl, benzooxazelyl, benzeisexazolyl, ful‘£)[2,3' blpyridinyl, beiizothmpheiiyl, LS-nephthyridinyl, ,2—b}pyridine, [l,2,4]triazole{l,5~ alpyi‘idinyl, benze [1,2,3]trlazolyl, imldazo?,Z—ajpyrimldiriyl, {l,2,4}triazolo[4,3—blpyi‘idazinyl, benzeEeHl ,2,5}tliiatliazolyl, bends][1,2,5]0xadiazole, l,3~dihydre-2H~benze[d?midazel?wne 3,4—dihyer—erl~pyi'eml0il,SJD} [l ,2} oxazinyl, 4,5,6,7—tetral’iydmpyrazeloEl ,S-alpyridinyl, tl’iiamlol5,4—dlthiazolyl, imidazelll—b}{l,3,4}thiediazelyl, thienoEZS~lijpyrmlyl, or 3l-l—indolyl.
In some embodiments, A is selected from the group ting of phenyl, riaplitliyl, pyridyl, l3enzol'iii'ei'iyl, pyrazinyl, pyridazmyl, pyrin'iiclinyl, triazinyl, ine, benzexemle, bei'imtl’iiamle, lH-benzimidazole, isequmeline, quinazoline, quirioxeline, pyrrole, indele, bipheiiyl, pyrenyl, and anthracenyl. in some embedimen‘ts, A is phenyl. in some embodiments, A is an aryl er earyl ring system as described in US Patent No. 9,855,545, which is hereby incorporated by reference in its entirety. {8356} En some embodiments, A is the pelymerizatiori preduct 0f cially available cliiseeyanates. For example, in some embedimen‘ts, A is the pelymerizatien product of cially available eryl diiseeyenates including but net limited to 2,4—toluene diisecyariete, 2,6—t0luene cliiseeyanate, 4,4’~metliylene diphenyl cliiseeyanate, 2,4’umethylene diphenyl diisocyanete, l,3—bis(iseeyanatemetliyl?ienzene, l ,3—bis(l misocyanetoul arnetliyletliyl)benzene, 3,3’udichiore—4,4"—diisocyanatou1,1’uhiphenyi, 3,3‘udinrethyimli?‘—hiphenyiene diisocyanate, 4,45 oxyhisiphenyi isocyanate), 1,3—phenyiene yanate, 1,4—phenyiene diisocyanate, 4—chioro—6_ methy1u1,3~phenylene diisecyanate, and l"chlorornethyi—Z,4ndiisocyanatohenzene. in some embodiments, A is where the wavy hne represents any of the tuents attached to A as defined . In sonre ©/O\.m140 embodiments? A is or where the wavy hne represents any of the tuents attached to A as defined herein. In some the Me where the wavy hne represents any of the substituents attached to A as defined, herein, the —Me, —C1, and —CH2—Cl groups bound to the aryl ring in the preceding structures corresponds to R} groups, and the — CEL— and —C(Me)2— groups hound to the aryi ring correspond to L groups. In some where the wavy hne represents any of the substituents ed to A as defined herein, and the Me and ---CE groups bound to the aryE ring in the preceding structures corresponds to R1 groups. {@857} The porous polymeric material of the present discios ure comprises a phrrahty of cyeiodextrins with a pturality of nks comprising formula (I). The piurahty of cyciodextrins of the present disclosure may he any cyeiodextrin containing from six to twelve glucose units. For example, in some embodiments, the plurality of cyclodextrins of the present disclosure are selected from the group consisting of u—cyclodextrin, B—cyclodextrin, y— extrin, and ations thereof In some embodiments, each cyclodextrin is a it cyclodextrin. {8858} The R‘1 groups of the plurality of crosslinks comprising formula (I) are each R1 is independently selected from the group consisting of H, C1—C6 alkyl, (ii—Ca haloalkyl, aryl, heteroaiyl, (To, -S()3l-l, ---CN, ~NO2, ~Nl-l2, —NCO, —C(0)2R3, —C(O)N(R3)z, and »---halogen. In certain ments, each R] is independently selected from the group consisting ofl-l, (Ii—Cs allryl, CiuCi lialoalkyl, aryl, heteroaryl, 4:? ’3, "803E, —--CN, —N{)2, uNl-lz, —NCO, —C(0)2R3, u C(O)N(R3)2, and --——lialogen. ln certain embodiments, 0—8 R1 groups are present on the plurality of crossliiilrs comprising formula (l). For example, 0, l, 2, 3, 4, 5, 6, 7, or 8 R} groups are present on each of the individual crosslinlrs comprising formula (1). lt is tood that any positions of A not substituted with R], R3, uW—Z or ML" will be unsubstituted or have one or more H atoms as required to satisfy the valency of that position. As will be appreciated by a skilled artisan, the number of R1 groups on each of the individual crosslinlrs of formula (i) may vary throughout the porous ric material of the present disclosure. For example, when Rl is —l§' and the rized porous material of the present invention is exposed to reactants capable of substitution (eg. choline chloride), the —F groups on some inks will be substituted, whereas in other crosslinlrs, the —F groups may be effectively shielded from the reactants and thus not react. ingly, a porous polymeric material of the present disclosure may have multiple g groups of formula (I) present, and each individual linlring group may independently have 0—8 (eg. l, 2, or 3) R1 groups. {@939} ln some embodiments, the porous polymeric material of the t disclosure may be characterized as having, on e, a fractional number of R1, R2, JWnZ or —L— groups in each crosslmking group This fractional number of substituents can be calculated by dividing the total number of such groups by the total number of crosslinhs in the porous polymeric material. For example, if half of the inlring groups are functionalized with a —O—CH2—CH2—N(Me)3l group (e.g where W is a —0—CH2—CHz— and Z is 3), then the average number (or fraction) of —O—CH2—CH2—N(Me)il groups corresponding to ~W—Z per crosslinking group is 05.
For R1, the fractional number of such groups includes values of about 0, about 0. l, about 0.2, about 0.3, about 04, about 0.5, about 0.6, about 07, about 08, about 09, about 1.0, about 1.1, about 1.2, about 1.3, about 14, about 1.5, about 1.6, about 17, about 1.8, about 1.9, about 2.0, about 2.1, about 22, about 2.3, about 2.4, about 25, about 2.5, about 27, about 2.8, about 2.9, about 3.0, about 3.1, about 3.2, about 3.3, about 3.4, about 35, about 3.6, about 3.7, about 38, about 3.9, about 4.0, about 4.1, about 4.2, about 4.3, about 44, about 4.5, about 4.6, about 4.7, about 4,8. about 4.9, about 5.0, about 5.1, about 5.2, about 5.3, about 5.4, about 5.5, about 5.6, about 5.7, about 5.8, about 5.9, about 6.0, about 6.1, about 6.2, about 6.3, about 6.4, about 6.5, about 6.6, about 6.7, about 6.8, about 6.9, about 7.0, about 7.1, about 7.2, about 7.3, about 7.4, about 7.5, about 7.6, about 7.7, about 7.8, about 7.9, or about 8.0, ive of a11 ranges between any of these va1ues. For R2, the fractiona1 number of such groups ino1ut1es va1ues of about 0, about 0.1, about 0.2, about 0.3, about 0.4, about 0.5, about 0.6, about 0.7, about 0.8, about 0.9, about 1.0, about 11, about 1.2, about 1.3, about 14, about 1.5, about 1.6, about 1.7, about 1.13, about 1.9, about 2.0, about 2.1, about 2.2, about 2.3, about 24, about 25, about 2.5, about 2.7, about 2.8, about 29, about 3.0, about 3.1, about 32, about 3.3, about 34 about 3. 5, about 3.6, about 3.7, about 313, about 3.9, or about 4.0, ino1usive of a11 ranges between any ot‘tbese va1ues.
For ~W—Z, the fractiona1 number of such groups es va1ues of about 10, about 11, about 1.2, about 1.3, about 1.4, about 1.5, about 1.6, about 1.7, about 113, about 1.9, about 2.0, about 2.1, about 22, about 2.3, about 2.4, about 25, about 2.5, about 2.7, about 28, about 2.9, about , about 3.1, about 32, about 33, about 3.4, about 35, about 3.6, about 3.7, about 38, about 3.9, or about 4.0, ine1usive of a11 ranges n any of these va1ues. For »---1...~, the fractionaE number of such groups ino1udes va1ues of about 1.0, about 11, about 1 .2, about 1.3, about 14, about 1.5, about 16, about 1.7, about 1.8, about 19, about 2.0, about 21, about 22, about 2.3, about 24, about 2.5, about 25, about 27, about 2.8, about 29, about 3.0, about 3.1, about 3.2, about 3.3, about 34, about 3.5, about 3.6, about 37, about 3.8, about 3.9, or about 4.0, ino1usive of a11 ranges between any of these va1ues. {0060} Each R3 is independen?y 11, —()1-1, "()umeta1 cation, a11 meta1 cation, ----Sua11 embodiments, each R3 is 431-1. 1n some embodiments, each R2 is ~0umeta1 cation. 1n some embodiments, each 132 is a11ty1. 1n some embodiments, each R2 is and (eg, substituted or unsubstituted bbeny1 or naphtbyl). 1n some embodiments, each 13.2 is betei'oaryE (e.g., substituted or unsubstituted 5— or berec1 heteroary1 rings with one, two, or three ring beteroatoms ed from the group consisting of O, S, or N). in some embodiments, each R3 is —SH. in some embodiments, each R2 is --——Sumetal cation. in some embodiments, each R3 is "Smallryl. in accordance with embodiments of the present disclosure, there may he l, 2, 3, or 4 Kg groups.
For example, 0, l, 2, 3, or 4 R) groups are t on the plurality of crosslinks comprising formula (l). As will be appreciated by a d artisan, the number of R) groups on each of the individual plurality of linking groups comprising a (l) may vary by each individual linking group throughout the porous polymeric material of the present disclosure. Accordingly, a porous polymeric material of the present disclosure may have multiple linking groups of formula (l) present, and each individual linking group may independently have eg. 0, l, 2, 3, or 4 R3 groups.
When there are more than one R2 groups on the plurality of linlring groups of formula (I), the R2 groups may be the same or different. For e, in some embodiments, one or more R2 group is —Ovmetal cation and one or more R2 group is —0H. {earn} Each R3 is independently —H, —Cl-C6 alhyl, —Ci—C3 haloall —C(O)RC, —C02Rc, -SOzN(Ra)(Rb), or —SORC, and each R3 and Rh is independently H, or Ci—C6 alkyl. in some embodiments, each R3 is Me, In some embodiments, each R3 is H. When R3 is aryl, the aryl may be, for example, a substituted or unsubstituted phenyl or naphthyl, {6962} in certain embodiments, x, is L4. For example, x may be l, 2, 3, or I—‘l. in some embodiments, x, is l or 2 and R1 is —l:7. {6963} in certain ments, yi is L4, For example, y i may be l, 2, 3, or 4. in some embodiments, yi is l~2. {6964} in certain ments, yz is l or 2. {0965} in certain embodiments, ys is O or l. {9966} in certain embodiments, the porous polymeric material of the present disclosure comprises a plurality of cyclodextrins crossliiilred with a plurality of crosslinks sing formula (ll): wherein yz is l or 2; and x is l or 2. in some embodiments, yz is 2 and x is l. In some ments, each cyclodextrin is B—cyclotlextrin. {(130367} in certain embodiments, the porous polymeric material of the present disclosure comprises a ity of linlrers of formula (Ill): l—o H N . N OVA, l / Y N o 0 lg) 9 R4 . R4 Cl (ill) {sues} wherein one R4 is 4H and one R4 is —Me. in some embodiments, each cyclodextrin is B—cyclodextrin.
{W69} in various embodiments, the porous polymeric material of the t sure is prepared by crosslinlring cyclodextrins of the same structure with crosslinkers of the same structure. in some embodiments, the porous polymeric material of the present disclosure is prepared by crosslinlring cyclodextrins of the same structure with two, three, four, or more different crosslinlrers, In various embodiments, the porous polymeric material of the present disclosure is prepared by crosslmlring two, three, or four different extrins (ie, having different structures) with crosslinlrers of the same structure In some embodiments, the porous polymeric material of the present sure is prepared by crosslinlring two, three, or four different cyclodextrins with two, three, four, or more different crosslinkers. {(3979} lo some embodiments, some of the crosslinlrs of the porous polymeric al do not include a cationic or c moiety (re, corresponding to group "Z" of a (1)). In such embodiments, the porous polymeric material comprises a plurality of erosslinkers of a (I) and a plurality of crosslinlrers haying a structure similar to that of formula (l), except that there is no cationic or anionic moiety corresponding to group "Z". So, for example, such crosslinlrers lacking a cationic or anionic moiety can have any of the crosslinlrer structures described in US Patent No. l0,086,360, herein incorporated by reference for all purposes, including, for example a plurality of crosslinkers of the following structure (a): regime/i \ structure l:a ll or the following structure (b): structure (b), or a combination of structures (a) and (b) (where X in structure (h) is 0,, l, 2, 3, or 4). In such embodiments of porous polymeric materials having crosslihlrers of structure (a) arid/or structure (b), such materials also include charged crosslmlrers of formula (l) as described herein, {9971} In still other embodiments, the porous polymeric materials of the present disclosure comprise a plurality of cationic crosslihlrers of the following ure (c): structure (c) (where X' is a pharmaceutically acceptable anionic oounterion such as C l ). {9972} In still other embodiments, the porous polymeric materials of the t sure comprise a plurality of cationic ihlrers of the following structure (cl): ure (d) (where x in structure (cl) is 0, l, 2, 3, or 4; and; X" is a pharniaceutically acceptable c counterion such as Cl"). {(130373} ln still other embodiments, the porous polymeric materials of the present disclosure comprise a plurality of cationic crosslinkers of structure (c) and a plurality of cationic crosslinkers of structure (cl). As described herein, any crosslinkers of the present disclosure having an aromatic halide group can be modified to proyide a charged moiety, for example by reaction with e chloride under suitable conditions as described herein. {8874} In other embodiments, the porous polymeric materials of the present disclosure se a plurality of anionic crosslirrkers of the following structure (e): ?at; i :2 2 at yo «3 structure (e).
Ellll’75l 'l'he cationic counterion for structure (e) (depicted as Na? can atively be any other pharmaceutically acceptable cationic counterion such as, without tion, H+ or {0076} ln yet other embodiments the porous polymeric materials of the present disclosure comprise a plurality of c crosslinkers of the following structure (f2): structure (f) (where x in structure (f) is Oa l2 2., 3 or 4)" {0077} In still other embodiments, the porous polymeric materials of the present disclosure comprise a ity of cationic crosslinlrers of structure (e) and a plurality of cationic crosslinlrers of structure (itm {0078} in some embodiments, the present disclosure provides a porous ric material comprising a plurality of cyclodextrin moieties crosslinlced by one or more polyisocyanates. in some ments, the plurality of cyclodextrins are ?—cyclodextrin. lii some embodiments, the one or more polyisocyanates are aiyl diisocyanates including but not limited to luene yanate, 2,6—toluerie yanate, 4,4’~methylerie dipheriyl diisocyanate, 2,4’~methylerie diphenyl diisocyanate, 1,3"his(isocyanatomethyl)benzene, 1,3-bis(l—isocyanato—l _ methylethyDbenzene, 3,3’"dichloronit-A’—diisocyanato~l,l’m‘oiphenyl, 3,3'mdimethy1ncl?’n biphenylene diisocyanate, 4,4’—oxybis(phenyl nate), enylene diisocyanate, L4" phenylene diisocyanate, 4—ch1oro—6—methy1nl,3—plienylene diisocyanate, and inclilorornethylmléln diisocyanatobenzene, and combinations thereof. ln some embodiments, the aryl diisocyanate is 2,4-toluene diisocyanate in some embodiments, the one or more oeyanates are aliphatic diisocyanates including but not limited to 4,4"—diisocyanato—methylenedicyclohexane (Hlvl‘?l), hexamethylene diisocyanate (EDI), isopliorone diisoeyanate (lPDl), l_.~lysine diisocyanate (LEI), trimethylhexametliylene yanate (TREE, s(i,soeyanatomethyl)cyclohexane, 1,4— diisocyanatobutane, trimethyl—l ,6~diisocyanatohexane, 1,6—dii socyanato—2,2,4—trimethylhexane, transd ,4—cyelohexylene diisocyanate, l,8-diisocyanatooctane, 1,12—diisocyana‘tododecane, and combinations thereof in some en'ibodiinents, the plurality of cyclodextrins are odextrin and the one or more polyisocyanates are Z,4~toluene diisocyanates, in some embodiments, the porous polymeric material has a Brunauer—Emmetb’l‘eller (BET) surface area of about 10 mz/g to 2000 rnz/g. For example, in some embodiments, the porous polymeric material has a BET surface area of about l0 m2.«’g, 20 m2/g, 30 in2/g, 40 i'nZ/g, 50 ir12/’g, 75 inZ/g, 100 mz/g, 150 nil/g, zoo ng, 250 ng, soo mW’g, 350 mW/g, 400 nit/g, 450 ng soc ng, 550 ng one ng, 650 m2/’g, 700 rnz/g, 750 rh2/’g, 800 inZ/g, 850 mQ/g, 900 mZ/g, 950 Mg, lOOO rnz/g, 1050 rh2/’g, 1100 inZ/g, l150 inZ/g, 1200 mQ/g, 1250 mZ/g, l300 m2,/g,', 1350 mz/g, 1400 inZ/g, 1450 mQ/g, 1500 m2/’g, 1550 rnz/g, 1600 inZ/g, 1650 in2/'g, l700 mZ/g, 1750 mZ/g, l 800 rnz/g, 1850 in2/’g, 1900 inz/g, 1950 mZ/g to about 2000 mQ/g, including all integers and ranges tlierebetween. ln some embodiments, the porous polymeric material has an amine content from about 0 mmol/g to about 1.0 minol/g. ln some embodiments, the porous polymeric material has an amine content from about 0.1 mniol/g to about 1.0 nimol/g. in some embodiments, the porous ric material has an amine content from about 0.15 mmo1/g to about 0.35 mmol/g. For e, in some embodiments, the amine content may be about 0.15 nimol/g, about 0.16 mmol/g, about 0.17 mmo1/g, about 0.18 mmol/g, about 0.19 mmol/g, about 0.20 mmol/g, about 0.21 nimol/g, about .22 mmol/g, about 0.23 mmol/g, about 0.24 mmol/g, about 0.25 mmol/g, about 0.26 mmol/g, about 0. 27 , about 0.28 mmol/g, about 0.29 mmol/g, about 0.30 , about 0.31 mmol/g, about 0.32 mmol/g, about 0.33 mmol/g, about 0.34 mmol/g, and about 0.35 mmol/g including all ranges therebetween Without being bound by any particular theory, it was discovered that by using asnis CD (re. undrietl) in the polymer synthesis, the resulting polymer had a higher amine content than similar polymers described in the prior art, which lerl to higher affinity for some micropollutants such as PFASs. {00791 In n embodiments, the molar ratio of oyclodextrin to linking groups of formula (1), (11), or (111) ranges from about 1:1 to about 1:31, wherein X is three times the average number of e subunits in the cyelodextrin. 1n n embodiments, the molar ratio of oyclodextrin to linking groups of formula (I), (11), or (111) is about 1:6. 1n certain embodiments, the molar ratio of oyolodextrin to g groups of formula (1) (11,), or (111) is about 1:5, 1n certain embodiments, the molar ratio of cyclodextrin to linking groups of formula (1), (11), or (111) is about 1:11. 1n eertain embodiments, the molar ratio of oyelodextrin to linking groups of formula (1), (11), or (111) is about l :3. in certain embodiments, the molar ratio of cyelodextrin to linking groups of formula (1), (11), or (111) is about 1:2. 1n s embodiments, the molar ratio of cyclodextrin moieties to aryl eross1inl 1:1, about 115, about 1:2, about 1:25, about 1:3, about l :35, about 1:4, about 1 :45, about 1:5, about 1:55, about 1:6, about 1 :65, about 1 :7, about 1:75, about 1:8, about 1:85, about 1:9, about 1:95, about 1:10, about 1:105, about 1:11, about 1:115, about 1:12., about 1:125, about 1:13, about 1:135, about 1:14, about 1:145, about 1:15, about 11155, about 1:16, about 1:165, about 1:17, about 1:175, about 1:18, about 1:185, about 1:19, about 1:195, about 1:20, about 1:205, about 1:21, about 1:215, about 1:22, about 1:225, about 1:23, about 1:235, or about 1:24, including a1l ranges of ratios therebetween. in an embodiment, the molar ratio ot" cyclodeirtrin moieties to aryl crosslinlring moieties is about 122.5 to about 1:10. {0080} 1n some embodiments, a composition according to the present disclosure comprises one or more porous polymeric materials of the present sure and one or more support materials, where the porous polymeric material is bound (e.g covalently, adhesively, or mechanically bonded as described herein) to the support material. For example, in some embodiments, the composition comprises porous polymeric materials comprising a plurality of cyclodestrins crosslinlred with a plurality of crosslinlrs comprising formulatl), and/or (ll), and/or (ill).
Examples of support materials include cellulose (eg, cellulose ), carbon—based materials such as activated carbon, ne oxide, and oxidized carbon materials, silica, alumina, natural or synthetic polymers, and natural or synthetic polymers modified to include surface hydroxyl groups. One of shill in the art will recognize that any material with ical or other properties suitable to act as a t, which can covalently bond to the porous polymeric material, or can serve as a suitable support material if the porous polymeric material is adhesively bonded to the support via a suitable binder material. In an embodiment, the composition is in the form a membrane or a column g material. In an embodiment, the support is a fiber (eg a cellulose, nylon, polyolet‘in or polyester . to an ment, the support is a porous particulate material (eg, porous silica and porous alumina} In an embodiment, the support is a woven or non~woven fabric. In an embodiment, the support is a garment (such as a protective garment) or a surgical or medical drape, dressing, or sanitary article. {(3981} in some embodiments, the P~CDP may be grafted or bonded (eg chemically or mechanically bonded) onto a support to provide an adsorbent where the particle size and morphology are ontrolled to give ideal flow characteristics The term "mechanical bonc " refers to a bond formed between two materials by pressure, ultrasonic attachment, and/or other mechanical bonding process without the ional application of heat, such as mechanical entanglement. The al entanglement and wrapping of mi crofibrils to hold in place micron— sized particulate matter is a prime example of a mechanical bond. The term mechanical bond does not comprise a bond formed using an adhesive or chemical grafting. ln some ments, the PuCDl’ may be grafted or bonded {eg or ically bonded) onto a support to / 5 chemically provide an adsorbent where the particle size and morphology are r engineered (e.g by ation or milling) to provide particles with a wellucontrolled size and morphology to give ideal flow characteristics. {8882} The support complex may be prepared by a variety of methods, including conventional grafting methods. As used herein, the term "grafting" refers to covalently attaching lLCDl’s to a substrate surface through coupling ons between one or more functional groups on the ECU? and one or more functional groups on the substrate. in some embodiments, ng includes an "in situ" process as described herein in which cyclodextrins, linking groups of the present disclosure, and a substrate having surface bound nucleophiles (eg, hy dross/ls) are reacted together such that the linking groups of the present disclosure reacts with the hydroxyl groups of the cyclodextrins and the surface nucleophiles of the substrate, forming a P—CDP which is partially bonded via one or more linking groups of the present disclosure to the substrate. The substrate having surface hound nucleophiles include, but are not limited to hydroxyls (such as niicrocrystalline cellulose), amines, phosphines, and thiols. {9983} In some embodiments, "grafted" P—CDl’~support complexes are prepared by first synthesizing the l’~CDPs in a dedicated al r with te control of the reaction conditions and material purification to e optimized P-CDP particles. The PnCDPs are then chemically d with a suitably functionalized substrate. For example, a substrate functionalized with carboxylic acid groups (or activated fornis thereof such as acid halides, anliydrides, etc. known in the art) can react with one of more hydroxyls on the P—CD‘P to form an ester bond with the substrate. Alternatively, the P~CDP can be appropriately functionalized (eg, by selection of a functionalized cyclodextrin as described herein) of by a subsequent modification of the P—CDP such that it can react with suitable functional groups on the substrate.
Any suitable reaction chemistries can be plated, such as reactions between carboxylic acids (and derivatives thereof) and hydroxyls to form ester bonds, reactions between carboxylic acids (and derivatives th ereof) and amine groups to form amide bonds, reactions between isocyanates and alcohols to make urethanes, reactions between isocyanates and amines to make ureas, reactions n cyclic carbonates and amines to make urethanes, reactions between thiols and alhenes or alkynes to make ethers, reactions between epoxides and amine , photochemical reactions between acrylates, niethacrylates, thiols etc, and olefins, and so forth.
The reactive functional groups described herein can be on either of the 9—510? or substrate provided the reaction forms a covalent bond between the ate and the PACE? For example, of the ve functional groups are yls and carboxylic acids (forming an ester bond after reaction), the hydroxyl groups can be present on the PuCDP and the carbonyl groups on the ate or viceuversa. {8884} in other embodiments, the substrate can be coated with a "primer" having reactive functional groups as described above. The primer adheres to the surface of the substrate, and under suitable conditions can react with a suitably functionalized P433? to for a covalent bond between the P—CDP and the primer. {8885} The P—CDP particles may be engineered to achieve ic particle sizes. in some embodiments, the P—CDP is produced in the form of crosslinlred les which may require further reduction in size leg, for the es of forming stable sions or slurries, or in providing optimal flow characteristics). A variety of means that are readily apparent to a skilled artisan can be employed to reduce the le size of the l’nCDP such as ng or milling.
Grinding and milling can be employed to create smaller particles with sizes less than l micron.
Typical milling operations can be used by a skilled artisan and include both wet and dry milling.
Milling can be employed through a variety of s including, but not d to: ball mill, autogeneous mill, SAG mill, pebble mill, rod mill, Buhrstone mill, tower mill, vertical shaft impactor mill, and the like. Milling media includes, but is not limited to: metals, silicates, and other inorganic materials in various form factors including, rods, balls, and irregular shapes. In some embodiments, the milling is performed on dry RC1")? powder al in a dry process to produce a finer dry powder or on wet aqueous slurries of the P—CDP powder with or without emulsifying agents to produce a finer particulate dispersion. Eniulsifying agents may be used and are readily apparent to a skilled artisan, including, but not limited to: small molecule and polymeric surfactant compounds with nonionic, anionic, or ic character. A skilled n will appreciate that using fine particulate form factors will enable a variety ofbenefits, such as ( l) more stable aqueous dispersions that remain homogeneous over time by ing separation, (2) enable a high g of material by weight in the dispersion with values of 50% by weight or higher, (3) produce particulate matter that can be evenly coated or applied to various substrates, surfaces, fibers, yarns, fabrics and the like to produce a finished material with minimal perceptible changes in "hand," and (4) produce sions that are stable to dilution and blending with other emulsions or solutions such as binders, surfactants, g agents, or softeners. in some embodiments, the final particle diameter includes l0 micron, l0~l 5 micron, and lS—ZO micron, or ranges therehetween. {8886} lf larger particle sizes are desired, the composition may be granulated to form agglomerates of larger particle size. Thus, in some ments, granules (eg, self~supporting es) are produced from PuCDP particle powders of various sizes. Broadly, this process will transform P—CDP particle powders in the size regimes ranging from lu30 microns to granules in excess or" lot} microns, 200 microns, 300 microns, and larger. This process may be ed via granulation techniques common to the pharmaceutical industry {1721;152:500}; omenai’crrion Technology, Ed. Parilrh, D. 1%, 2005, Taylor & Francis Group) in which the powders are bound together via physical and/or chemical means in batch or continuous modes. ln the simplest form, particles of the P—CDP are blended mechanically with a fluid (cox, aqueous) mixture containing an adhesive hinder — typically a synthetic, ynthetic, or l polymer. Suitable semi" synthetic polymers that can be used include cellulose etheis, specifically ethylcellulose, methylcellulose. ypropylcellulose, carboxymethylcellulose, starch and starch derivatives, and . Suitable fully synthetic polymers such as polyvinylpyrrolidone or polyethylene glycol can be used. Other suitable hinders e sizes and other coatings used in the textile industry and paper industries including ide amine epichlorohydrin (FAB) or polymeric glyoxal crosslinlcers, polyvinylalcoliol, and starch~hased sizes. ln order to create robust granules which are resistant to dissolution in water or other solvents, r covalent crosslinking may he facilitated via the addition of small molecule crosslinhers such as l, formaldehyde, yanate, and/or diepoxide functionalities. in addition to nt crosslinlring electrostatic agglomeration of polyelectrolytes can also be utilized as a binding motif in which cationic polyelectrolytes form suitable adl'iesiye properties when blended with anionic polyelectrolytes in the presence of P-CDP powders and/or t structures. Polyca‘tions can comprise those commonly used for flocculation including, but not limited to polydiallyldimethylarnmonium chloride (polyDADh/lAC), acidic polyethyleneimine, and polyacrylamides. Polyanions can comprise those commonly used for flocculation including, but not limited to sodium polyacrylate, sodium polystyrene sulfonate, and polyvinylsulfonate. {(3887} ical blending during the granulation may he achieved via low shear processes such as rotary drum mixing or overhead mechanical stirring. As will be readily apparent to a slrilled artisan, the stirring rate and total length of stirring time effects the granule size.
Granulation may also he conducted in fluidized beds or via spray drying techniques. ln each case, the ECU? particle are combined with the aqueous or solvent borne mixture containing the binder compounds and the ical or physical agitation is conducted at a specified shear for a determined number of cycles. The ant particles will display a step growth change in their average diameters and can also display a changed polydispersity. The physical properties of these granules depend on the binder selected, the crosslinlring chemistry, and the al process used in their granulation. These larger granular particles will be suitable for packed bed column filtration commonly employed for water filtration and industrial separations. {8888} ln some embodiments, the present disclosure provides a stable aqueous dispersion comprising P—CDP particles. ln some embodiments, the 1’—CDP particles of the present disclosure, which can be used in such stable aqueous dispersions are from about l pm to about 150 urn. For example, the PCB? les are from about l, 2, 3, 4, 5, 6, 7, 8, 9, l0: ll, l2, 13, 14515,l6,l7,l8,19,20,2l,22523,24,25,26,27,28,29,3O,3l§32,33,34,35,36,37,38,39, 42,43,44,45,46,47,48,49,50,Sl,52,53,54,55,56,57,58,59,6u,ol,62,63,64,65, 66:67,6$,69,70,7l,72,73,74,75,76,77,78,79,80,8l,82,83,84,85,86,87,88,89,9u,9l, 92,93,94,95,96§97,98,99,l00,101,192,l03,104,105,l06,107,108,l99,llu,lll,ll2, ll3,ll4,l15,llo,ll7,118,119,120,12l,l22,123,124,l25,l26,127,128,l29,130,13h 132,133,l34,l35,136,l37,l38,l39,l40,l4l,142,143,l44,l45,l46,l47,l48,149,n3 about lSO pm A stable aqueous dispersion may be used in "grafting" ations. For example, the stable aqueous dispersion may be used in applications with chemical binders or lating fibers for mechanical loading and binding, and oration into thermally—bonded particulate pressed forms and into solution processed polymer form factors. {9989} The P—CDP als of the present disclosure can also be prepared on a support material (alternatively termed a rate"), for e covalently bonded, adliesiyely bonded, or mechanically attached to a support such as a fibrous substrate. The support material can be any material that has one or more groups (e. g, hydroxyl or amino, thiol, or phosphine, or other group as described herein) that can form an interaction (e,g a covalent or mechanical bond) with a crosslinlring agent or cyclodextrin. For example, one end ofa crosslinking agent (e.g the linking groups of Formulas (1), (11), and/or (111)) is covalently bound to the substrate material and another end of the crosslinking agent is covalently bound to a extrin glucose unit or a reactive center on modified cyclodextrin (such as an acid halide or activated ester bound to the cyclodextrin). lt is ble that the support material not dissolve (e.g to an observable extent by, for example, visual inspection, gravimetric methods, or spectroscopic methods) under use conditions, for example in aqueous media. Examples of support materials include, but are not d to, microcrystalline cellulose, ose nanocrystals, polymer materials (e.g acrylate materials, rylate materials, styrenic materials (eg, polystyrene), ter materials, nylon materials, and combinations thereof or inorganic materials (eg, silicates, silicones, metal oxides such as alumina, titania, zirconia, and hafnia, and combinations thereof). ln various examples, the polymer materials are hornopolymers, copolymers, or resins (eg, resins comprising polymeric materials). The support material may be hydroxyl or amino containing polymer beads or irregular particles. The support al can be in the form a fiber (cg, pulps, short cut, staple fibers, and continuous filaments), fiber bundles (e.g., yarn — both spun and continuous filament), fiber mats (eg, nonwovens — both staple and continuous filament), fabrics (eg, lrnits, woven, ens), membranes tog, films, spiral wound, and hollow fibers, cloth, particulate leg, a powder), or a solid surface. in some embodiments, the fibrous substrate is a osic substrate. Cellulosic substrates can comprise any suitable form of cellulose, such as cellulose derived from plant sources such as wood pulp (eg, paper or paper fibers), cotton, rated cellulose, modified cellulosics such cellulose esters and/or ethers, and the like, , polyvinyl alcohols and derivatives f. The cellulosic substrate can be in the form of a fabric, such as a woven or nonwoven fabric, or as fibers, films, or any other suitable shape, particularly shapes that provide high surface area or porosity. In a ular embodiment, the P— CDP materials of the present disclosure are bonded to , for e, a cellulosic fiber or a fabric, such as cotton. {(3899} In addition to the substrates listed in the ing paragraph, the substrate may include any of the following: polyvinylamine, polyethylenimine, ns, proteirnbased fibers (cg, wool), chitosan and amine-bearing cellulose derivatives, polyarnide, vinyl chloride, vinyl acetate, polyurethane, melamine, polyirnide, polystyrene, polyacryl, polyamide, te butadiene styrene (ABS), Barnox, PVC, nylon, EVA, PET, ose nitrate, cellulose acetate, mixed cellulose ester, polysulfone, polyether sulfone, polyvinylidene fluoride (PVDF) or polytetrafluoroethylene (PFTE or Teflon R), polyethylene, polypropylene, polycarbonate, ine or thiol functional materials, and silicone or combinations thereof. The substrate may also consist of silicon or silicon oxide, or glass leg. as inicrofibres). Suitable materials further include textiles or synthetic or natural fiberubased materials. The material may exhibit any form or shape and may for instance be in the form of a sheet, bead, granule, rod, fiber, foam or tube, and may be rigid, flexible or elastic. {$091} If necessary, the material surface may be activated by any method known in the art, such as known surface activation techniques, including for instance corona treatment, oxygen plasma, argon plasina, selective plasma hromination, al grafting, allyl try, chemical vapour deposition (CVD) of reactive groups, plasma activation, r coating, g, or any other known technique. For instance in the case of a glass surface, such an activation is y not required as such a surface is herein ered already activated. The purpose of the activation of the surface is to provide for a surface suitable for the covalent attachment of a surface—modifying functionality or (directly) of a primer r. Following its optional activation, the surface may he further functionalized. The purpose of the functionalization of the surface is to provide for functional group suitable for the covalent attachment of a prencoat polymer. {9992} The skilled artisan is well aware of the various possibilities of attaching polymers to optionally activated surfaces. These techniques generally involve the introduction of amino, silane—, thiol—, hydroxyl~ and/or functionalities to the surface, and the subsequent attachment o of the polymer. [9993} The functionalizati on may also comprise the introduction of s or linker to the surface for the ment of the primer polymer to the surface at a predetermined distance. A suitable spacer is for instance an alkylation by reacting the surface with for instance aininoalkylsilane. [9994} The P—Cf)? may he hound to the substrate via the linking groups of the t disclosure (eg. via a hydroxyl or amino group of the linking group). A c‘linlrer moiety" refers to the intervening atoms between the P—CDP and substrate. The terms "linker" and "linking moiety" herein refer to any moiety that connects the substrate and PCT)? to one another, The linking moiety can he a covalent bond or a chemical functional group that directly connects the P—CDP to the substrate. The linking moiety can contain a series of ntly bonded atoms and their tuents which are collectively referred to as a linlting group. in some embodiments, linking moieties are characterized by a first covalent bond or a chemical functional group that bonds the P~CDP to a first end of the linlter group and a second covalent bond or chemical functional group that bonds the second end of the linker group to the substrate. The first and second functionality, which independently may or may not be present, and the linker group are collectively referred to as the linker moiety. The linker moiety is defined by the g group, the first functionality if present and the second functionality if present. In certain embodiments, the linker moiety contains atoms interposed between the P—CDP and substrate, independent of the source of these atoms and the reaction sequence used to synthesize the ate. In some embodiments, the linker moiety is an aryl moiety as described herein. In some embodiments, the linker has one or more of the following onalities: multifunctional isocyanate (cg, a diisocyanate), epoxy, carboxylic acid, ester, activated ester, ic chloride, cyanuric acid, acid chloride, halogen, liydroxyl, amino, thiol, and phosphine {0095} In some embodiments, the ECU? is d or bonded onto microcrystalline cellulose (CMC). CMC is available in a variety of median particles sizes from about l0 — about 500 um including about l0 pin, 20 um, 45 ttm, 50 pm, 65 pm, 75 um, l00 uni, lSO um, l80 itin, l90 pm, 200 pm, 225 um, 250 pm, 275 pm, 300 pm, 325 um, 350 um, 375 pm, 400 um, 42:3 pm, 450 pm, 475 um, and about 500 um and all particle sizes tlierebetween, In some embodiments, I’uCDP is d or bonded onto CMC having a median particle size of about 50 um. In one example, CMC is commercialized as Avicelm, In other embodiments, the P—CDP is grafted or bonded onto a polymeric ate other than ose, as described herein, in which the surface is treated to produce surface functional groups as disclosed herein, such as yl groups. {00%} In some embodiments, the P~CDP—substrate complex (eg, a P—CDP crosslinked with an aryl linker of formula (l)~CMC substrate complex) has a polymer thickness tie, the thickness of the porous P—CDP particles on the surface of the substrate) of between about l nm to about 2000 nm. For example, P—CDP—substrate complex has a polymer thickness of about l, 2, 3, 4, 5, 6, 7, 8, 9, l0, 20, 30, 40, 50, 60, 70 , 80, 90, l00, l50, 200, 250, 300, 350, 400, 450, 500, 550, 600, 650, 700, 750, 800, 850, 900, 950, l000, l050, ll00, ll50, L200, l250, I300, I350, l400, l450, l500, l550, l600, l650, l700, l750, l300, l850, l900, l950, to about 2000 nm. In some embodiments, P—CDP—substrate complex has a polymer thickness or" less than 1000 nrn. In some embodiments, P—CDP—substrate complex as a polymer thickness of about 800 nm. As will be readily nt to a skilled artisan, a having a lower thickness (eg, less than l000 nm} will allow for faster kinetics to absorb contaminants, for example aqueous contaminants. {0097} In some embodiments, the substrate complex (eg a P—CDP crosslinked with an aryl linker or" formula (1)4)th substrate complex) has a contaminant tion capacity of up to 500 mg contaminant/g CD. For example, the adsorption capacity may be up to about l, 2, 3,4,5,6,7,8,9,10,15,20,25,30,35,40,45,SO,55,60,65,70,75,80,85,90,95,100,lOS, ll0,ll5,120,125,130,l35,l40,l45,l50,155,160,165,l70,l75,180,l85,190,195,200, 210,220,230,24o,250,260,270,zso,2ao,300,310,320,330,34o,350,3eo,37o,3so,390, 400, till), 420, 430, 440, 45G, 460, 470, 480, 490, to about 590 mg contaminant/g Cl). in some embodiments, the adsorption capacity is up to about 200 mg contaminant/g Cl). ln some embodiments, the contaminant is an anionic ollutant (eg. PFASS). In some ments, the cyclodextrin is B—cyclodextrin. ln some embodiments, the linking groups are the linking groups of Formulas (I), (ll), and/or (Ill). {9998} ln some embodiments, the substrate complex (eg, a P—CDP crosslinked with an aryl linlter of formula (l)~Cl\/lC substrate complex) has an equilibrium contaminant adsorption capacity of up to Sill) mg contaminant/g Cl). For example, the equilibrium adsorption capacity maybe up to about l, 2, 3, 4, 5, 6, 7, 8, 9, ll), l5, 20, 25, 30, 35, 40, 45, 5t), 55, 60, 65, '70, '75, so,ss,9o,95,ioo,ios,iio,iis,izo,i25,iso,135,14o,i45,iso,155,ieo,165,17o,i75, iso,iss,ieo,i95,200,2io,220,230,2ao,250,260,27o,2so,290,3oo,sio,320,330,340, sso,3eo,370,3so,390,aoo,4io,420,430,44o,450,4eo,47o,4so,490,aiaeautsooing contaminant/g CD. In some embodiments, the equilibrium adsorption capacity is up to about 200 mg contaminant/g Cl?~ In some embodiments, the contaminant is an anionic- ollutant (eg~ PFASs). ln some ments, the cyclodextrin is ll—cyclodextrin. in some en'ibodiinents, the lii'ikiiig groups are the linking groups of Formulas (l), (ll), r (lll).
} In some embodiments, the P~CDP—substrate complex (eg, a P—CDP crosslinked with an aryl linlter of formula (DEB/h: ate complex) has a tion time of less than 2 minutes, As will be appreciated by a skilled artisan, where processes with high relaxation times slowly reach equilibrium, while processes with small relaxation times adapt to equilibrium quickly. ln some embodiments, the contaminant is an anionic i'nicropolhitai'it (eg. . ln some embodiments, the cyclodextrin is odextrin. ln some embodiments, the linking groups are the linking groups of Formulas (I), (ll), or (ill). {lllllllll} ln some embodiments, any of the P-CDP materials disclosed herein are grafted or bonded onto CMC directly or via a linlter group as defined herein. ln some einhodin'ients, the P- CDP is homogenously distributed on the CMC surface. in some embodiments, the aryl linker is an aryl linker of formula (l). ln some embodiments, the aryl linker is a g groups of Formula (ll). in some embodiments, the aryl linker is a linking groups ot‘li'ormula (ill). ln some embodiments, the median particle size is about 50 pm. hi other embodiments, the median particle size is from about 1 about 250 am. {98191} CMC can also be distinguished by a particle shape known to impact flow characteristics among other things. A nonulimiting list of particle shapes includes spherical (round—shaped), rod— shaped, and needle—like. Particles can also be described as flat, flat and elongated, or be characterized by their aspect ratio. ln some embodiments, the CMC has a spherical particle shape. In some embodiments, the CMC is present in the form of agglomerates of r CMC particles. Such CMC agglomerates can have particle sizes in the range of 200 um up to about 2 mm. For example, the le sizes of CMC agglonierates can be about 200 um, about 300 um, about 400 pm, about 500 pm, about 600 urn, about 700 um, about 800 um, about 900 um, about 1 mm, about 1.2 mm, about l3 mm, about 'l.4 mm, about l5 mm, about 1.6 mm, about l7 mm, about 1.8 mm, about l9 mm, or about 2 mm, inclusive of all ranges therebetween. litltlllliZl ln some embodiments, the ECU? is grafted or bonded onto CMC via a linking groups of Formula (1). ln some embodiments, the ECU? is grafted or bonded onto CMC via a linking groups of Formula (la). ln some embodiments, the P—CDP is grafted or bonded onto CMC via a g groups ot‘Formula (ll). In some embodiments, the RC1")? is grafted or bonded onto CMC via a linking group of Formula (Ill), {@9193} ln some embodiments, P~CDP of the present disclosure is grafted or bonded onto CMC via an aryl linker, and the aryl linker is hoinogen ously buted on the CMC crystal In some embodiments, the median particle size is about 100 nm, lttttll‘ldl In addition to the use of CMC as illustrated herein, examples of other ial support materials include those materials described above, such as activated carbon, graphene oxide, as well as silica and alumina. {99195} ln some embodiments, it is desirable that the supported P~CDP materials disclosed herein (e,g a P—CDP inked with an aivl linker of formula (ll—CMC substrate complex) are in the form of les having a narrow dispersity of particle sizes. ln some embodiments, the particle size distribution has a low relative span of about 5 or less, where relative span is defined by the ratio iG}/’D50, where D90, D50, and Die are, respectively the diameters at which 90%, 50%, and 10% of the particles in the distribution have a smaller er. Suitable spans are no more than 5, 4.5, 4, 3.5, 3, 2.5, 2, l, 0.9, 0.8, 0.7, 0.6, 0.5, 0.4, 0.3, 0.2, or 0.l, including all ranges tlierebetween. {00106} In other various embodiments, the PuCDP may be d or bonded onto cellulose nanocrystais (CN Cs). CNCs are the crystalline regions of cellulose mici'ofibrils obtained after mechanical, chemical, and enzyme treatments. Depending on the source and, preparation method, CNCs are available with lengths ranging front about lml000 nni and, widths ranging from about 3-50 nm, inclusive of all values therehetween. For example, the CNCs have a length of about l, 2, 3, 4, 5, 6, 7, 8, 9, l0, l5, 20, 25, 30, 35, 40, 45, 50, 55, 60, 65, '70, '75, 80, 85, 90, 95, ion, l50, zoo, 250, 3m, 350, 400, 450, soc, 550, eon, 6.50, 700, 750, see, 850, sec, 95a, to about 1000 nrn. The CNCS have a Width of about 3, 4, 5, 6, '7, 8, 9, l0, ll, l2, 13, 14, l5, l6, l7, is, 19, 20, 2t, 22, 23, 24, 25, 2e, 27, 2s, 29, so, 31, 32, 33, 34, 35, 36, 37 3s, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, or about 50, In some embodiments, the P~CDP~CNC substrates may he 2- 3 times the size (length, and width) as the unbound CNCs. The CNCs are further characterized by aspect ratio values (LCD) ranging from about 2~l 00 (George, J, et at, Cellulose nanoorystals: synthesis, tirnctional properties, and applications, .Z‘v’anotechnofogu Science andApplications. —54). For example, the CNCs have an aspect ratio of about 2, 5, l 0, 15, 20, 25, 30, '35, 40, 45, so, 55, no, 65, 7o, 75, so, as, so, 95, too, 105, no, its, 120, i25, l30, i35, 140, MS, 150, L55, ieo, res, i7o, i75, iao, 135, l90, l95,01‘l00. {00107} In some ments, the P~CDP is d or bonded onto (INC via the linking groups are the linking groups of?nmulas (l), (ll), and/oi (ill) as described herein. ln some embodiments, the P-CDP is grafted or bonded onto CMC via a linking groups of Formula (I). In some embodiments, the P~CDP is gratted or bonded onto CMC via a linking groups of Formula (II). in some embodiments, the P—CDP is grafted or bonded onto CMC via a linking groups of Formula (111).
} In some embodiments, P~CDP is grafted or bonded onto CNC via a linker, and the linker is homogenously distributed on the CNC crystal. In some ments, the median particle size is about 100 nm. {@8199} (INC can also be distinguished by particle shape known to impact flow characteristics among other things. A miting list of particle shapes includes spherical (round—shaped), rod— shaped, and needle—like. Particles can also be described as flat, flat and elongated, or be characterized by their aspect ratio. In some embodiments, the CNC has an aspect ratio of between about 5 to about lQQ. For examples, the aspect ratio may be about 5, l0, l5, 20, 25, 30, , 40, 45, 50, 55, 60, 65, '70, 75, 80, 85, 9t), 95 to about lt‘it‘i. In some embodiments, the CNC aspect ratio is about 20—25. In some ments, the CNCs are needle—like. In some embodiments, the CNC is present in the form of erates of smaller CNC particles. Such CNC agglomerates can have le sizes which are 5400 times larger than the sizes of the individual particles, depending on the sizes and number of the particles constituting the aggregates.
} In some embodiments, the substrate is a fabric or fiber. 'I‘hus, in some embodiments, the present sure provides a composition comprising a I’nCDP grafted or bonded (e. g, chemically or mechanically) to a fiber. In some embodiments, the PCB? is grafted or bonded onto a fiber yia the linker of formulas (I), (II), and/or (III), as bed herein. In some embodiments, the fiber is a nonwoyen fiber. In some embodiments, the present disclosure provides a ition comprising a P—CI)P grafted or bonded (eg chemically, adhesively, or mechanically) to a fabric. In some embodiments, the P—CDP is grafted or bonded onto a fabric via the linker of formulas (I), (II), or (III), {titlllll Fibers suitable for use include, but are not limited to fibers sing any of the polyi'ners disclosed herein, for example fibers made from highly oriented polymers, such as gel— spun ultrahigh molecular weight polyethylene fibers (e.g, SPECTRA® fibers from Honeywell Advanced Fibers of Morristowri, Nl and DYNEMA® fibers from DSIVI High Performance Fibers Co of the Netherlands), melt-spun polyethylene fibers (eg, CERTRANG?) fibers from se Fibers of Charlotte, NC), melt~spun nylon fibers (eg, high tenacity type nylon 6,6 fibers from Invista of Wichita, Kans), melt—spun polyester fibers (e.g high tenacity type polyethylene terephthalate fibers from lnyista of Wichita, Kans.), and ed polyethylene fibers (eg, ’l‘ENSYLON?i‘) fibers from l'l‘S of Charlotte, NC). Suitable fibers also include those made from rigidurod polymers, such as pic rigid~rod polymers, heterocyclic rigid~rod polymers, and thermotropic liquid—crystalline polymers. Suitable fibers also include those made from regenerated cellulose including reactive wet spun Viscose rayon (Viscose from Birla of lndia or Lenzing of Austria}, cuproaniinoniurn based ray on (Cupro® rg,‘ from Asahi Kasei of Japan), or air gap spun froni Nit/{MO t cel?'s) from Lenzing of Austria). Suitable fibers made from lyotropic rigidurod polymers include araniid fibers, such as polylpu plienyleneterephthalainide) fibers (egg, KE’VLARGE fibers from DuPont of Wilmington, Del. and ’l‘WARONd‘) fibers from 'l‘eijin of Japan) and fibers made from a l:l copolyterephthalaniide of 3,4’"dianiinodiphenylether and ylenedianiine (cg, 'l'ECHNORA® fibers front 'l'eiiin of lapan). Suitable fibers made from heterocyclic rigidmrod polymers, such as ylene lieterocyclics, include poly(pnphenylenen2,6-benzobisoxazole) fibers (PEG fibers) (cg.
ZYLON® fibers from 'l'oyobo of Japan), polytpnphenylenenf/l,ombenzobisthiazole) fibers (PBZT fibers), and, ?—diimidazold,5—b:4",5’—e}pyridinylene—l,4—(2,5nrliliydroxy)phenylene} fibers (PIPE) fibers) (ego, M5® fibers from DuPont of Wilmington, Del). Suitable fibers made from therinotropic liquidmcrystalline polymers include —hydroxy~2~napthoic acid—coalit— hydroxybenzoic acid) fibers (erg, VECTRAN® fibers from Celanese of tte, NC).
Suitable fibers also include carbon fibers, such as those made from the high temperature pyrolysis of rayon, rylonitrile (eg, OPF® fibers from Dow of Midland, Mich), and mesoniorphic hydrocarbon tar (eg, THORNEL® fibers from Cytec of ille, SC). In certain ly preferred embodiments, the yarns or fibers of the e layers comprise fibers ed from, the group consisting of gel—spun ultrahigh molecular weight polyethylene fibers, spun polyethylene fibers, melt—spun nylon fibers, melt—spun polyester fibers, sintered polyethylene fibers, aramid fibers, PEG fibers, PBZT fibers, PIPE) fibers, poly'(6—hydroxy—2— napthoic acid—co—d—hydroxybenzoic acid) fibers, carbon fibers, and combinations thereof~ {$49112} The P—CDP materials of the present disclosure can be adhered to such fibers by means of a suitable binder polymer as described herein, or chemically bonded to such fibers by functional izing the surface of the fibers as bed herein (cg, surface oxidation to produce surface yl groups) and either forming the P—CDP in situ on the fiber surface, or by reacting a suitably functionalized P—CDP directly with the functionalized fiber surface, or indirectly Via a linlrer moiety as described herein. {98113} The fibers may be converted to nonwoyens (either before or after attachment of the P— 010?) by different bonding methods. Continuous fibers can be formed into a web using industry standard spunbond type technologies while staple fibers can be formed into a web using industry standard carding, airlaid, or wetlaid technologies. Typical bonding methods include: calendar (pressure and heat), thru—air heat, mechanical entanglement, hydrodynamic entanglement, needle punching, and chemical bonding and/or resin bonding. The calendar, thru—air heat, and chemical bonding are the preferred bonding methods for the starch polymer fibers. Thermally le fibers are required for the pressurized heat and thru—air heat bonding methods.
{Mill/l} The fibers of the present invention may also be bonded or combined with other synthetic or natural fibers to make nonwoven articles. The synthetic or natural fibers may be blended, together in the forming process or used in discrete layers. Suitable synthetic fibers e fibers made from opylene, polyethylene, polyester, polyacrylates, and, copolymers thereof and mixtures thereof. Natural fibers include cellulosic fibers and derivatives thereof.
Suitable cellulosic fibers include those d from any tree or vegetation, including hardwood fibers, softwood fibers, hemp, and, cotton. Also included are fibers made from sed natural cellulosic resources such as rayon. {titlll?l The fibers of the present invention may be used to make nonwovens, among other suitable articles. Nonwoven articles are defined as articles that contains greater than l5% of a plurality of fibers that are continuous or non—continuous and physically and/or chemically attached to one another. The nonwoyen may be ed with additional noriwoyens or films to produce a d product used either by itself or as a component in a complex, combination of other materials. Preferred articles are disposable, nonwoven articles. The resultant products may find use in s for air, oil and water; textile fabrics such as rniero fiber or breathable fabrics having improved moisture and odor absorption and softness of wear; ostatieally charged, structured webs for collecting and removing dust and pollutants, medical textiles such as al drapes, wound dressing, bandages, dermal s, textiles for absorbing water and oil for use in oil or water spill clean—up, etc" The articles of the present invention may also include disposable ens for hygiene and medical applications to absorb off~odors Hygiene ations include such items as wipes; diapers, particularly the top sheet or baclr sheet; and feminine pads or products, particularly the top sheet. {lllll 16} The yarns or fibers of the textile layers can have any suitable weight per unit length (cg denier). Typically, the fibers have a weight per unit length of about l to about 50 denier per nt (l to about 50 g per 9000 meters). The yarns contain a plurality of filaments from l0 to about 5000. {98117} ln some embodiments, the PuCDP is adhesively bound to a substrate such as a fiber or fabric Via a binder. ln some embodiments, the P—CDP is coated on a ate such as a fiber or fabric via a binder. in some embodiments, the P—CDP is bound to or coated on a substrate such as a fiber or fabric via a binder by ucing the surface to stable aqueous dispersions of the P— CDP particles in conjunction with binders. 'l'he P—CDP particle dispersion may be l~50% by weight and a polymeric binder material may be present in an emulsion or solution in l~50% by . For example, the P—CDP particle dispersion may be present at about 1, 2, 3, 4, 5, 6, 7, 8, 9,10,ll,12,13,l4,l5,l6,l7,l8,l9, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 3l, 32, 33, 34, , 36, 3'7, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, or about 50% by weight. The polymeric binder material may be present in an emulsion or solution at about l, 2, 3, 4, 5, 6, 7, 8, 9, l0, ll, 12, i3, l4, l5, l6, 17, is, l9, 2o, 21, 22, :23 :24, 25, 2e, 27, 2s, 29, 3o, 31, 3:2 33, 34, 35, 36,, 37, 38, 39, 40, 4l or about 50 % by weight. Additional auxiliary , 42, 43, 44, 4-5, 4-6, 47, 48, 49, agents can be used as minor components by weight to control the wetting by the substrate (wetting agent), on foaming or de—foarning, softening agent for substrate hand, and/or catalyst for binder curing. {99118} A variety of coating techniques known in the art can be applied, such as: dip and squeeze, solution casting, foam coating, or spraying of the formulated solution onto the substrate of interest. Substrates include, but are not limited to: woven, knit or nonwoyen fabrics, continuous filament yarns, spun yarns, spun fibers, wood es, and thermoplastic surfaces.
In some embodiments, upon application of the formulated on to the substrate, the ed system will be dried to remove the water solvent at which time an even film of P—CDP particles mixed with polymeric binder will be present During the drying process, the binder material present as an emulsified polymer will llow together and hecorne a continuous phase. ing on the choice of hinder, the P—CDP particles may be held in place through mechanical means or adhesion to the binder continuous phase only, or additional covalent linkages could be present if a ble binder is selected. Such covalent linkages could extend the ying substrate which would further increase the durability of the P—CDP particle coating. {99119} As will be readily apparent to a d artisan, the resultant PuCDl’ particle filin conforms to the underlying substrate and is durable to physical abrasion, and washing such that the article can be deployed. Furthermore, if the P—CDP particles have access to the aqueous or vapor phase within the coating, they will demonstrate the same selective and high affinity small molecule adsorption characteristics as the monolithic particles. Such form factors can be converted into filter cartridges, pleated filters, nonwoven needlepunched filters, hygienic nonwovens, and l.
{M13129} A variety of s known to a skilled artisan may he used in the context of the present disclosure, such as any of those disclosed in US Patent Publication No. 20l4/Ol78457 Al, which is hereby orated by reference in its entirety. Suitable hinders include, but are not limited to, latex binders, isocyanate hinders (eg, blocked isocyanate s), acrylic binders (eg, ic acrylic binders), ethane binders (eg, aliphatic polyurethane binders and polyether based polyurethane binders), epoxy hinders, urea/formaldehyde resins, inelarnine/fornialdehyde resins, polyvinylalcohol (PvOH) resins (disclosed in US Patent No. ,496,649, which is hereby orated by reference in its entirety) and crosslinked forrns thereof, poly—ethylenevinylalcohol (EvOH) and crosslinked forms thereof, polym ethylenevinylacetate (EVA), starch and starch tives, cellulose ether tives, and cellulose ester derivatives, Small molecule, polymeric or inorganic crosslinhing agents could be used additionally including formaldehyde, glyoxal, diisocyanates, diepoxides, and/or sodiuni tetraborate, and combinations thereof. {(39121} ln some embodiments, the P—CDP particles are mechanically bound to a surface, such as a fibrillating fiber Fibrillating fibers are used to create high surface area, extended networks which can wrap around and entrap particulate matter. Fibers such as fibrillating polyolefin (such as Mitsui Fybrel®), fibrillating regenerated cellulose (such as Lenzing TencelTM) or lating c (such as Sterling Fibers CFFTM) are deployed in wet laid ses to create specialty papers which excellent mechanical properties, good wet strength, and the ability to hold particulate matter (US Patent No. 4,565,727, which is hereby incorporated by reference in its entirety), Onxy Specialty Papers, l-lelsa Corporation, and others. in particular, powdered activated carbon particles with diameters greater than 5 microns have been loaded into specialty carbon papers that are deployed in liquid and vapor filtration applications such as point of use water filters or cabin air filters, {hill 22} ln the paper rnahing process, an s dispersion or slurry blend of short cut fibers (such as wood pulp, ter, nylon, or polyolel’in), fibrillating fibers (such as Fyhrel®, 'llencell‘M, or CFF’E‘M), and particle powder material are mixed (eg, under high shear). This mixture can then be rapidly passed through a nonwoven mesh or screen to deposit a wet laid nonwoven web. This web is dried (eg, in hot air oven or on heated rolls) to remove the water carrier. Further bonding may be achieved through cold or hot calendaring either in flat format or with a patterned roll to produce the bonded specialty paper. The particulate powder used can be a dispersion of P—CDP ulates of defined particle size. Particulate size can be set Via grinding and milling techniques as defined previously. The particulate loading in the finished nonwoven can he as high as 60% by weight. The particulate can be used alone or blended with other particulate such as powdered activated carbon. Additional chemical binders, such as those described herein, may be used to alter or enhance the properties of the paper and will be applied as one skilled in the art. {bulls} The resultant powder loaded papers are amenable to a high g of KGB? adsorbent particles in a convenient paper filter form factor for water and/or air filtration. The paper can be used in the flat form, cut into a variety of , or pleated and bonded into a filter media cartridge. lZK-ll in some embodiments, the PCB? particles are ically entangled in yarn leg, continuous filament yarn). In some embodiments, the P—CDP particles are mechanically entangled in continuous filament yarn. As will be readily apparent to a skilled artisan, a special subset of yarn finishing enables the mechanical binding of ulate matter within a continuous filanient yarn in some circumstances. When a yarn leg, uous filament) comprised of multiple filaments of a l tic polymer such as polyethyleneterephthalate (PET) or polyamide (nylon 6 or nylon 6,6) that bears n'iicrofibrilla‘ting tendencies on each nt surface, there exists the possibility to incorporate particulate within the yarn s. The P— CDP particles of the present sure can be incorporated into the yarn in a variety of ways One non—limiting example is to apply a dispersion of the P—CDP les of interest via dip coating or oil roll application onto a moving yarn bundle during the false twist texturing process. ln this process, the filaments are mechanically separated via twisting, first in one direction followed by the opposite direction. After the first ng, the filaments are individualized and void space is presented within the yarn bundle. The dispersion solution is applied at this point within the process after which the bundles are twisted back to the standard orientation and the yarn heated to dry the solution. This process enables the application of dispersion particles within the yarn bundles that are held in place by the continuous filaments and microfibrils emanating from the continuous filament surface. Such approaches have been used to apply various micron sized particles to continuous filament yarns, including microcapsules (US Patent Publication No. EGGS/0262646 Al which is hereby incorporated by reference in its entirety), metallic silver inieroparticles (US Patent Publication No. 36l595 Al which is hereby incorporated by reference in its ty), and (US Patent Publication No. 2006/0067965 Al, which is hereby incorporated, by reference in its entirety) other functional particles to synthetic fiber yarn bundles. These ed and particle loaded yarns may then be processed through typical means to create knit and woven fabrics for use in apparel, upholstery, medical, displays, or other uses. {99125; In some embodiments, the PSI)? particles are incorporated, into thermally—bonded, particulate pressed forms. A common form factor for powdered absorbent material is in thermally/"bonded pressed forms. Such form factors can contain as high as 95% by weight lb CDP particles, with the addition of fibrillating fibers (Fybrel?l), 'l'encel"M, or Cll‘FTM), sometimes inorganic materials such as attapulgite clays, and finally an organic binder material (most typically ose esters and similar tives) to create a porous ite structure with adequate mechanical strength and particulate holding efficiency for medium pressure filtration ations such as faucet filters and refrigerator filters (US Patent Nos 5,488,02l and 8,l6’7, l 4i both of which are hereby incorporated by reference in their ties). {£39126} P—CDP dry les or dispersion can be used in place of or blended with other adsorbent materials to form such a composite adsorbent P—CDP particulate—containing forms as described above In such embodiments, the solid dry ents may be dry blended, optionally including dry P-CDP particles and organic binder powder with or without inorganic clays and/or fibrillating , If an aqueous dispersion of P—CDP les is used, they may be diluted with water and added to the mixture. Water is added (egg in 80~l 50 wt%) and the mixture is blended (eg under high shear) to create a plastic material. This n'iaterial may be formed into the desired form factor, dried and cured at temperatures ranging from l25 to 250 "C.
This final form factor presents the PCB? adsorbent particles in a form factor common to and useful for point of use water filters, {99127} in some embodiments, the P~CDP particles are oration into solution sed polyiner form factors. A, variety of means are available to produce filter membrane materials.
For example, via solution cast films or extrude hollow fibers of membrane polymers where controlled coagulation creates a sed film of controlled pore size. ln some embodiments, a polymer such as ose acetate dissolved in a water miscible organic solvent such as NMP, DMSQ, or 'l‘llF is used. This solution can be cast as a film into a water bath which causes rapid coagulation of the ose acetate polymer and densification of the film. These films may be processed on roll to roll equipment and many layers are wrapped to create a spiral wound membrane filter for use in micro—filtration, ultranfiltration, gas filtration, or reverse osmosis applications. In place of cellulose acetate, common polymers used include polyamides, efins, polysulfones, polyetliersulfones, nylidene fluoride, and similar engineered thernioplastics. It is also possible to extrude hollow fibers into the aqueous solution to create membrane fibers through the phase inversion process that are ltnown as hollow—fiber membranes commonly used for dialysis, reverse s, and desalination applications. ionizer in some embodiments, the PnCDP particle matter is incorporated into membrane material to enhance the performance of the ne materials. For example, it is possible to have present in the aqueous coagulation bath a small quantity of P—CDP particle dispersion that will become incorporated into the dense ns or porous portions of the membrane during the phase ion process. A, second manner to incorporate the PCB? particles into the membrane is the incorporation of a small amount of wellvdispersed particles into the organic on of the membrane polymer that become encapsulated in the membrane following coagulation. Through each of these methods? the production of P-CDP loaded polymer forms may be enabled. in various embodiments, such as micro—filtration, ultra-filtration, and reverse osmosis, the P—CDP particle incorporation acts to enhance the n'iicropollutant ren'ioval of the membrane system. {@0129} in some embodiments, the PCB? particles are incorporated into melt extruded th ermoplastics (cg fibers and molded . Having access to small diameter dry powder P~ CDP particle material of low polydispersity enables its incorporation into melt processed polymer forms including fibers and molded parts. Typical thermoplastics of use include hyleneterephthalate, yesters, polyolefins, and ides. Typical extrusion temperatures are between 250—300 "C and therefore l’uCDP particle stability to those temperatures either under air (most preferred) or inert here is required. Single or twin— screw extrusion is used to blend and mix the powdered material at elevated temperatures under shear with the thermoplastic in up to five weight percent. Once adequately mixed, the blended components can be extruded through small round or otherwise shaped orifices and drawn to produce fibers bearing the particulate matter linear densities ranging from l to 20 denier per filament. A common particle added to most thermoplastic fibers is titanium dioxide added to whiten and deluster the fiber. The l’nCDP particles will be added in a similar fashion. ln the most ideal embodiment, the l’nCDP les will migrate to the surface of the fibers and bloom due to their higher surface energy such that a portion of the particles are present and accessible by the vapor or liquid phase. in other embodiments, instead of extruding the polymer melt through small orifices, it can be blow molded or otherwise melt processed to produce a plastic part. This plastic part will also bear the PnCDP particles that bloom to the surface and become active for the removal of small molecule micropollutants leg. anionic Mill’s) from the vapor and liquid phase. {lilililll} The P—CDP of the present disclosure can be supported or formed into a variety of shapes (or formmfactors) suitable for various applications. For example, the P—CDP materials of the present disclosure can be in the form of powders, granules, formed into discs, eg, in a cellulosic al such as paper or other non—woven forms, or ed or pressed into various shapes suitable for, eg, filtration, water treatment, sample absorption, etc. as described herein, {@9131} While it is not unknown to provide adsorbents in a. supported form, it is important that the methods used to affix the adsorbent to the substrate or support are sufficiently robust so as to and the use conditions. Further, the means of attachment to the substrate should not ere with or block the adsorption mechanism of the ent. The adsorbents disclosed herein can be ed to supports, as described herein, so that the resulting performance characteristics are only minimally ed by the attachment . in various embodiments, the supported polymeric materials of the present invention provide mance characteristics which are at least 50% of the same performance characteristic which would be ed by the same ition of adsorbent prepared without a support material (based on equivalent amounts of the ent) when measured under identical conditions. So for example a porous al grafted to microcrystalline cellulose (eg, a l’uCDP crosslinked with an aryl linker of formula (l)_Ch/lC substrate complex) may have at least 50% of one or more of a particular performance characteristic found in unsupported porous material tested under the same conditions. {98132} in some embodiments, the performance characteristic can be the amount of uptake l:adsorption capacity) of a particular pollutant, measured as the milligrams of ant adsorbed per gram P—CDP particle under particular conditions. ln other embodiments, the performance characteristic can be the brium tion capacity (tie), defined as discussed herein as: our," qt? m gmax CQKL+1 wherein qmm (mg pollutant/g adsorbent) is the maximum tion capacity of the sorbent for a particular ant at equilibrium, K1, (mol‘l) is the brium nt and (:8 (mid) is the pollutant concentration at equilibrium {99133} ln still other embodiments, the performance teristic is the rate at which brium adsorption of a ant is reached (rate of equilibrium tion for a particular adsorbent. This rate can be expressed as the time ed for a supported or unsupported RC1")? of the present disclosure to reach equilibrium for a particular adsorbed species (or pollutant), {99134} ln still other embodiments, the performance characteristic is the rate at which competing adsorbents sequester pollutants. Competing adsorbents may he unsupported P—CDPs as described herein, or other agents, such as activated carbons (powdered or granular), ion- exchange resins, and specialized resins used for solid—phase niicroextraction (eg, HEB), {(38135} For any of these performance characteristics disclosed above, the performance of the supported P—CDP ot‘ the present disclosure is at least about 50%, 60%, 70%, 80%, 90%, WOO/E), l20%, 140%, least, {80%, 2009/9, 220%, 2a %, zoos/ii, 280%, 300%, 350%, 4a %, 450%, 500% or greater, inclusive of all values, ranges, and subranges therebetween compared to unsupported P~CDP of the same composition, tested under essentially the same conditions, eg, with the same pollutant, temperature, pressure, exposure time, etc, {(38136} The performance characteristics of the present disclosure can be measured, for example based on bisphenol A or PFASs or another suitable specie as disclosed herein, by a variety of s which will be readily apparent to a skilled artisan. For example, the contaminant may be measured at initial concentrations of EPA or another suitable specie ranging from l ppb (or l microgram/L or 5 nM) to l ppt (or l g/L or 5 rnM} in any aqueous sample, including but not limited to drinlring water, wastewater, ground water, aqueous extracts from contaminated soils, landfill leachates, purified water, or other waters containing salts, or other c matter. The pl-l may be range from 0—l4. For example, the pl-l may be 0, l, 2, 3, 4, 5, t3, 7, 8, 9, l0, ll, l2, 13, or l4, inclusive of all ranges therebetween. The mance teristics may be ed ntially as described herein (eg, in Examples l and 2), with routine modifications (such as temperature and pressure) also being envisioned. {@9137} in some embodiments, the present disclosure provides an article of manufacture comprising one or more P—CDl’s or one or more P—CDlLsuhstrate complexes of the present disclosure. {98138} ln an embodiment, the article of manufacture is protective equipment. in an embodiment, the article of manufacture is clothing. For example, the article of manufacture is clothing sing one or more P—CDPs or one or more P—CDl’nsubstrate complexes of the present disclosure leg, clothing such as a uniform at least partially coated with the porous polymeric al or. ition). In another example, the article is filtration medium comprising one or more P—CDPs or one or more P—CDl’nsuhstrate complexes of the present disclosure. The filtration medium can be used as a gas mask filter. in an embodiment, the article is a gas mash comprising the filtration medium. In some embodiments, the article is an extraction device. {99139} In another embodiment, the article is a solid phase microphase (Si’lvfl'i) extraction device comprising one or more PUCDPs or one or more nsubstrate complexes of the present disclosure, where the P—CDPs or PmCDPeubstrate complexes is the ting phase the device {@9149} ln another embodiment, the article is a device for a solidmphase extraction of polar and semi,~polar organic molecules. The device comprises one or more P~CDPs or one or more P- CDP~suhstrate complexes of the present disclosure d oflllB media (hydrophilic/lipophilic balanced). The article with the one or more P—CDPs or one or more P~CDP~suhstrate complexes forms the Hill media.
Willi-ll} ln another embodiment, the article is a device for liquid filtration of polar and semi— polar organic molecules. The. device comprises one or more RCDPS or one or more Fvlelll substrate complexes of the tt disclosure adhered within a s web (as disclosed in US.
Patent No. 7,655,l l 2., which is hereby incorporated by reference in its entirety). Other embodiments include the device comprising P-CDP powders fused via thermoplastic hinder polymer to create porous monolithic filtration media (as disclosed in US Patent No. 4,753,728, which is hereby incorporated by reference in its entirety). {98142} The P—CDP materials of the t disclosure, in the various forms and form factors disclosed herein (including supported and unsupported P—CDP materials) can be used in any application in which it is ble to separate compounds (eg anionic or cationic MPs) from a fluid l:gases such as air, liquids such as water, aqueous beverages, biological fluids, etc). The l)— CDP als can be used to "trap" or adsorb desired species for further is or quantification (eg, in analytical g for environmental pollutants in air or water), to separate mixtures (eg, in a chromatographic separation), or to isolate ble or valuable species which are present as a dilute form in a fluid. in some embodiments, the P—CDP materials of the t disclosure can be used to purify a fluid (eg, by removing undesirable or noxious impurities), or can be used to isolate desirable compounds from a e or dilute fluid solution. ltltllclizll ln some embodiments, the present sure provides a method of removing one or more compounds (eg. anionic MPs) from a fluid sample or determining the presence or absence of one or more compounds in a fluid sample comprising: a) contacting the sample with the porous polymeric al of the present disclosure or the supported porous polymeric material of the present disclosure for an incubation period; b) separating the porous polymeric material or supported porous polymeric material after the incubation period from the sample; and c) heating the porous polymeric material or supported porous polymeric material separated in step b), or contacting the porous polymeric material or supported porous ric material separated in step b) with a solvent, y releasing at least a portion of the compounds from the porous polymeric material or ted porous ric material; and dl) optionally isolating at. least a portion of the compounds released in step c), or d2) determining the presence or absence of the compounds released in step c), wherein the presence of one or more compounds correlates to the presence of the one or more compounds in the sample, in some embodiments, the one or more extrin moieties are li—cyclodextrin moieties, in some embodiments, said determining is carried out by gas chromatography, liquid chrornatography, supercritical fluid chromatography, or mass spectrometry. in some embodiments, said contacting is by g the aqueous phase across, over, around, or through the supported porous polymeric material. in some embodiments, the aqueous sample is contacted with the l’uCDPusubstrate complex under static conditions for an incubation period and after the incubation period the aqueous sample is separated from the porous ric material. In some embodiments, the sample is a food and the compounds are volatile organic compounds. In some embodiments, the aqueous sample is drinlring water, wastewater, ground water, s extracts from contaminated soils, or landfill leachates. In some embodiments, the sample is a perfume or fragrance and the nds are volatile organic compounds. In some embodiments, the compounds are anionic micropollutants, heavy metals, and/or dyes. In some embodiments, the compounds are anionic MPs, such as PFASs (eg. polyfluorinated alhyl compounds and/or perfluorinated allryl compounds). ln some embodiments, the PEASs are PFOA and/or l’FOS. 339144} In an embodiment, a method of purifying an aqueous sample comprising one or more organic compounds is provided, the method comprising contacting the aqueous sample with the porous polymeric material of the present disclosure or the supported porous polymeric material of the present sure such that, for example, at least St‘i‘Z/o to at least 99% of the one or more pollutants is bound to one or more of the cyclodextrin (cg, ?cyclodextrin) moieties of the porous polymeric material. For example, the aqueous sample is flowed across, around, or through the porous polymeric material. in another example, the aqueous sample ted with the porous polymeric material or the supported porous polymeric material under static conditions for an incubation period and after the incubation period the aqueous sample is separated (e. g, by filtration) from the porous polymeric material. The method can be used to purify aqueous samples such as drinking water, atei', ground water, aqueous extracts from contaminated soils, and ll tes, In some embodiments, the organic compounds are anionic lVlPs, such as PFASs.
{MIME} In an ment, a method of determining the presence or absence of compounds (eg, anionic MPs) in a sample comprises: a) contacting the sample with the porous polymeric material of the present disclosure or the supported porous polymeric al of the present disclosure for an incubation period (eg, l minute or less, 5 minutes or less, or l0 minutes or less); b) ing the complex from a) from the sample; and c) heating the complex material from b) or contacting the complex from b) with a solvent (eg, methanol) such that at least part of the compounds are then released by the porous material; and d) determining the presence or e of any compounds, wherein the presence of one or more compounds correlates to the presence of the one or more nds in the sample, or isolating (e.g by filtration) the compounds. For example, the determining (eg, analysis) is carried out by gas chromatography or mass spectrometry. For example, the sample is a food or beverage (eg, mill<, wine, fruitjuice {e.g., orange juice, appleiuice, and grapeiuice), or an alcoholic beverage (eg, beer and spirits)) and the compounds are volatile organic compounds. The porous polymeric material or supported porous polymeric material can be the extracting phase in a solid phase microextraction {SPF/1E) device. In some embodiments, the organic compounds are anionic lit/3’s, such as PFASs. {@9146} in an embodiment, a method for removing compounds (eg, organic compounds) from a sample comprises: a) contacting the sample with the porous polymeric material of the present disclosure or the supported porous polymeric material of the present disclosure for an incubation period such that at least some of the nds are sequestered in the polymer; b) isolating complex from a) from the sample; c) heating the complex from b) or contacting the complex from b) with a solvent (cg, methanol) such that at least part of the compounds are released by the porous ric material; and d) optionally, isolating at least a portion of the compounds. ln some embodiments, the compounds are anionic N 3‘s, such as l’FASs. {99147} Ayariety of compounds can be involved (cg, sequestered, detected, and/or isolated) in the methods. The compounds can he organic nds. The compounds can be desirable nds such as tlayorants leg, compounds that impact the palatability of foods) or pharmaceutical compounds (or pharmaceutical intermediates), inants leg, PCBs, PBAs, etc), and/or adulterants In some embodiments, the compounds are c lit/[P5, such as PPASs. ln some embodiments, the compounds are anionic MPs selected from the group consisting of genifibrozil, oxybenzone, enac, ioxynil, ketoprot‘en, naproxen, sulfamethoxazole, warfarm, 2,4—dichlorophenoxyacetic acid, clol’ibric acid, ibuprofen, 2—methyl—4—chlorophenoxyacetic acid, mecoprop, yalsartan, perthrorobutanoic acid, perlluorobutane sult‘onic acid, pertluoropentanoic acid, oropentane sulfonic acid, peril uorohexanoic acid, pertluorohexane sulfonic acid, peril uoroheptanoic acid, peril uoroheptane sult‘onic acid, pertluorooctanoic acid, peril uorooctane sull’onic acid, uorononanoic acid, pertluorononane sulfonic acid, perthrorodecanoic acid, periluorodecane sulfonic acid, periluoroundecanoic acid, orododecanoic acid, perlluorotridecanoic acid, perl'luorotetradecanoic acid, 2,3,3,3—tetrailuoro—Z— (heptatluoropropoxy) propanoate, and combinations thereof.
} The cyclodextrins are chiral. in an embodiment, a chiral compound is sequestered, detected, and/or isolated. in an embodiment, a chiral column (eg, a preparative—scale or analytical—scale column is packed with a chiral porous polymeric al or composition comprising chiral porous polymeric material) is used to separate and detect or isolate (or at least significantly enrich the sample in one enantiomer} a single enantiomer of a compound.
{B9149} ln the methods, the porous polymeric material or the supported porous polymeric material can be regenerated {e.g., for reuse in the methods). For, example, the porous polymeric al is regenerated by heating and/or exposure to solvent (e.g alcohols such as methanol or ethanol, and aqueous mixtures thereof). {@9159} The following examples are provided to illustrate the present disclosure, and should not be construed as limiting thereof. e 1: Synthesis DETDl polymer {B9151} Reagents: 841D: , Cavarnax W7 (Used as~is); Tolylene—2,4_cliisocyanate ('l'Dl): Sigma Aldrich, 95%, Product # T398533; N,l\l"Dimethylformamide (EMF): Fisher Chemical, ied ACS grade, Catalogti Dllguél; Water; Deionized (Dl) water from Milli—Q system {@9152} Procedure: ?—CD (60.0 g, 0.0529 rnol, l erg.) was dissolved in l20 mL EMF in a 500 mL oneuneck round hottorn flask at a magnetic stir rate of 400 rpm and the temperature was set to 80 "C. An oil bath equipped with couple was used for heating. After tely dissolving B—CD, 'l'Dl (36.8 g, 0.21l5 mol, 4 eq.) was added subsequently to the flask at 80 0C.
Air bubbles were observed likely due to the presence of water in the reaction medium. After about 1 min when there was no bubble ed, the flask was capped with a rubber septum.
After 3 h, the reaction was stopped by adding 30 mL of methanol and turning off the heating.
The resulting viscous clear solution was precipitated into 1.2 L methanol to obtain white powder product. After l h ng, the crude product was filtered under vacuum using a Buchn er funnel.
The filtered polymer powder was transferred back to a 2~L beaker and washed again with 1.5 L DI water \ 2 times and l2 L methanol X 1 time During each cycle the washing time was l h.
After final filtration, wet solid product was transferred to an ating dish, which was placed into a vacuum oven at 80 °C to yield 726 g dry polymer, lt was observed that starting at a 6 equivalence of Till and above, a hard gel is obtained which is ditficult to work up. In contrast, TELCD ratios in the range of 2: l—S: 1 provide a powder material upon stopping the reaction with methanoi (Table 1}. These rs are aiso soiuhie in a variety soiyents such as DIVE but not in water. See Fig. 5 for a further comparison of the polymers of Table 1.
Table 1: Synthesis of ?—CD—TDE poiynieis Materiai h—fggbi Soivent "1" 9(3) Time Yieid Notes SL-E—GGtA 1:4 Anhydrous DMF 80 15 h 58% White powder* ESL-20828 1:? Anhydrous DMF 80 15 h We Get SL-O()2C 1:8 Anhydrous DMF 80 ’15 31 111a Gei ESL—2002B 1:1(3 Anhydrous DMF 80 16 h We Gei SL—2-004A 1:2 Anhydrous DMF 80 3 h 36% White powder SL—2~004B 1:3 Anhydrous DMF 50 3 h 55% White powder SL004C 1:4 Anhydrous DMF so 3 h 61% White powder SL~2~604D 1:5 Anhydrous one so 3 h 72% White powder SL004E 1:6 Anhydrous DMF 80 3 h We Get *Washed with oix1,water x 2, and methanoix1. {(38153} fi~CD—TDI ntion Studies {@9154} The ?~CD—TDI poiymer was r optimized by checking the hty of BSD (es~is and dried) in reguiar and ous DMF, the i'esuits of which are shown in Table 2. As—is B~CD has a water content in the range of 12— i 4% water.
Table 2: Soivents and iii-CD water coi'itent comparison in the synthesis of B-CD—TDI polymers Solubility test Register DMF Anhydrous EMF Asais £34312) 0.5 giant. 0.5 giant.
Bried sen 0.25 g/mL 0.22 g/mL ; As shown in Table 2,, the soiuhiiity of B—CD is significantly affected based on its water content. Consequently, when dried, {LCD is used, the poiyineiizntion can only he carried, out iowei initial concentrations that impact reaction yields. In comparison, the water content of DIVE? is insignificant and therefore has iess impact on the soluhihtyt prompting us to use regular DIX/ll: in the reaction. A comparison of ButiDuTDl polymers made via small and large scale s is shown below in Tahle 3.
Table 3: A comparison of {B—(IDJl‘Dl polyrners rnaole via small and large scale s Material antigen (anhydrous) {Till} (mollL) T ("Cl Time Yield volume SL~1~010A 1:47 4 mL 176 80 3 h 7§% 03 1:4? 120 ml. 1.78 80 3 h 82% Water content of B—CD used: 111% {99156} lt was usly understood that the use of dried til—CD and anhydrous solvents was critical for nialong polyurethane~type Cl) polymers; however, as described herein, using c‘wet" solvents (also referred to as "regular" solvents) such as EMF and/or as~is Ell—CD, the resulting polymer is structurally different than the polymers described in the literature and are much more effective for PFAS sequestration, It was surprisingly ered that using gular solvents resulted in partial isocgranate reduction, shown below in Scheme l for TDli Scheme l: Effects of water on isocyanate groups of "?ll 7} The presence of amine groups into the polymerization reaction is believed to result in the formation of urea linkages in addition to the urethane linkages which result from the crosslinlring of {hill} and TDl under anl'iydrous conditions (eg‘ completely anhydrous conditions). onally, the presence offree arnines in the B—CD-TDl polymer are believed to contribute to PFAS removal. The high amine and urea content provides a polyn'ier that is structurally different from the prior art and which is more advantageous for the rernoval of anionic niicropollutants (cg. PEAS). {$19158} tal analysis data shows that final CD:TDl ratio is l:8~l :lO when a feed ratio of lt4 is used, which suggests the presence of excess 'l‘Dl units on cyclodextrins. Additionally, 1H NMR spectroscopy shows the presence of~-—Cl-l3 protons resulting from the arnine functionalized phenyl unit (Fig. 3}. Amine groups can be quantified using the "(ll-l3 peak at ~l.9 ppm that ates from a ‘TDl unit with amine groups on it. The ratio of that integration to total integration of -—-—Cl-l3 pealrs provide the percentage of TDls with amines. Since absolute ‘T‘Dl y can be calculated from the elemental analysis data, the concentration (mmol/g) of amine groups in the polymers can be calculated by correlating Nl‘le and EA data. See Table 4. The 33- CDnTDl r additionally tested positive in the chloranil test, further confirming the amine presence.
Table 4: Determination of amine content of meDnTDl polymers made with regular Eli/ll: NEVER integration {based on one pnCD unit} tal Analysis CD:TDl TDHED TDEKBD Sample C?gttotal) CHglamlne) Amine (0/6; {TDQmmot/‘g {Aminegmmol/g feed ratio ratio ratio SL—1-O‘i0A 114.7 0.15 SL—QnOD'IA 1:4 0.17 Sl_.—2u003 1:4.7 0.16 SL004A 1:2 0.34 SL004B 1:3 0.22 SLmZ-OMC 1.4 3.21 SL—2n004D 1:5 0.16 {88159} The amine—containing SEE—ml polymers were further tested t a panel of l2 PFASs (fig. l} as well as against the binary mixture ot‘l’EOA and PEOS (Fig. 2). The polymer made with 4 eq. oi" TDT (:SL— l —0l 0A) showed 70% removal of PFQA and excellent l of PFOS (96%} in only 30 min and reached nearly 90% PFQA and l00% PFOS removal over 48 h in the panel study. A similar removal performance was also observed when tested for the binary mixture of PFOA and PFOS.
Example 2: Synthesis and PEAS l activity of ?—C?mlsocyanate polymers litltlltitl} Following the general procedure outlined in example l, ?~£§Duisocyanate polymers obtained from 4,4’uMDl were synthesized and tested for their ability to remove . {99161} The polymers of Table 5 were tested for their ability to remove PFASs. All experiments were ted with l000 ng/L of each of l2 Pli'ASs and l0 mg/L of adsorbent. Control experiments were performed with no adsorbent. These experiments were conducted in triplicate.
Samples were taken at the following times: 0 h, 0.5 h, 9 h, and 48 h. Fig. l shows the results at 0.5 and 48 h, with polymers made from 4,4’—MDl and 2,4~‘T‘Dl being particularly effective at PFAS sequestration. Although faster l lrinetics was observed in the 'l‘Dl polymer (SLul _ 010A), the MDl polymer 20~3) also had good removal performance over the course of 48 h. Polyrners obtained from 6 eq. of Hill and MDl did not t good removal of either PFOA or PFOS, most lilrely due to the formation of hard gel during their synthesis which renders binding sites ssible in the particle.
Table 5: {luCD polymers made with different isocyanates Polymer Cresslinker C?zisocyanate ratio Sleeved from scrum DA 2,4x-TDl 1:4 230 mesh SL-l -O1OA 2,4--TD! 1:6 80 mesh SLnlnMQO-S 4,4'—l\/lDl 1:4 230 mesh 514—04204 D! 1:6 8-3 mesh Example 3i: Synthesis and PEAS removal activity of choline chloridewmodi?ed ?wCD~TFN polymer {Blil?l} In this e, positive charges were added onto CD polymers in order to enhance the binding affinity for anionic PFASs Without being hound hy any particular theory it is believed that the ce of phenol groups produced in a side reaction during polymerization results in anionic charge on the polymer and diminishes the PFOA and PFOS uptake of polymers. This effect was experimentally ohserved in another polymer ation? TFN—CDP, which demonstrates good removal performance against a hroad range of micropollutants except negatively charged ones including PFASs. 'l‘FNuCDP can he ed in relatively large scales using tetrafluoroterephthalonitrile (TFN) as the crosslinker Therefore, it was desired to modify the adsorption properties for PFASs by incorporation of positive charges on the polymer backbone. in this example, choline chloride------a quaternary ammonium salt with a hydroxyl group------was chosen as an additive to the polymerization reaction of TEN—(EDP. e chloride can react with TFN just like ?—CD and thus is incorporated into the polymer, which hereafter will be denoted as TEN—CDPi- e 2).
Scheme 2: Synthetic overview for choline chloride—modified l3—CD—l‘FN polymers Table 6: Synthetic conditions and yields for TFN-CDP+ rs ß-CD TFN TFN-CDP+ BPA MO Sample ß-CD TFN K2CO3 CC Yield [B-CD] [CC] Uptake Uptake Sample Name ß-CD eq.Name eq. eq. TFN eq. eq. K2CO3 eq. CC eq.eq. Yield (%)(%) Crosslinker:CD Crosslinker:CD [ß-CD] (mmol/g)(mmol/g) [CC] (mmol/g)(mmol/g) BPA Uptake (%)(%) (%) MO Uptake (%) MB 036 MB036 11 6 6 20 20 33 8181 5.5 5.5 0.37 0.37 0.63 0.63 74 74 >99% >99 % MB 037 MB037 11 6 6 20 20 66 7474 5.6 5.6 0.35 0.35 0.96 0.96 67 67 >99% >99 % *CC: Choline de. BPA uptake measured under following conditions: [BPA]0 = 23 ppm, [Polymer] = 1 mg/mL, Contact time = 1 min. MO uptake measured under ing conditions: [MO]0 = 10 ppm, [Polymer] = 1 mg/mL, Contact time = 1 h.
Table 7: Porosity comparison for TFN-CDP+ polymers Sample e Chloride (eq) Surface area (m2/g) 36 3 574 MB037 6 19 Table 8: Elemental analysis for TFN-CDP+ polymers C F Cl Feed equivalents Ratios TFN:CD Sample (mmol/g) (mmol/g) (mmol/g) ß-CD TFN CC C:N N:F N:Cl F:Cl C:Cl ratio MB036 1 6 3 7.45 2.23 7.51 3.36 55.98 5.49 35.2 2.1 0.63 MB037 1 6 6 7.19 2.73 5.07 1.86 36.44 5.64 35.1 1.8 0.96 Prior to measuring PFAS removal, a comparison of BPA (a neutral molecule) and methyl orange (MO, a negatively charged dye molecule) uptakes of TFN-CDP and TFNCDP + was performed. While BPA uptake was not ed, MO uptake was significantly improved, from ~30% for TFN-CDP to >99% for TFN-CDP+. As ed, TFN-CDP+ polymers demonstrated significantly less affinity towards positively charged molecules such as methylene blue compared to P (Table 9; Fig. 7). Encouraged by this preliminary data, TFN-CDP+ was tested for the removal of PFOA and PFOS at environmentally relevant concentrations.
Table 9: MP removal efficiencies of choline chloride modified and unmodified TFN-CDP Sample BRA Methyl Orange Methylene Blue pliant—036 74% 99% 34% M84 ~03? 57% 99% 10% TFN—CDP 80% 30% 160% {sales} Although further experiments are needed to fully characterize the adsorption mechanism, this approach allows one to (l) take advantage of dual g mechanism (inclusion complex with B—CD and ionic interactions) at the same time in a single material and/or {2) enhance the g affinity of the inclusion complex through the presence of positive charges in the vicinity of CD cavities. Furthermore, TFN—CDP-r is still synthesized in one step and the amount of ve charges incorporated can be easily modified by changing the amount of choline de used in the reaction. {(130165} Experimental: 1}ij (l g, 0.88l mniol), TEN (l .06 g, 5.286 nimol), lizCGs (2.44 g, l7.62l , choline chloride (0.37 g, 2.643 mmol), and 5.4 mL HzO/DMSO (2:3, v/v') were added to a 20—mL scintillation vial equipped with a ic stir bar. The mixture was stirred at 60 °C for 2f: h. Additional t (1 mL) was added after the first hour of stirring. After 20 h, 10 mL of water was added and stirred to disperse the polymer for 30 min. After filtering, the crude product was transferred to a fuge tube. The sample was washed with hot methanol ("\rllOmL) three times (3 0 min for each cycle). After decanting ol, Dl water (~30 mL) was added. 1 M HCl was added dropwise while stirring the sample until the pH was stable between 3—4. The crude product was further washed two more times with hot methanol (~49mL). The final ol wash was filtered under vacuum and product was dried at 80 "C overnight. {anion} Testing PFOA and PFOS removal performance — PFAS adsorption experiments were performed to measure the removal performance of different TFN—CDP+ polymers. In an effort to facilitate the screening process for a large number of polymer formulations, adsorption kinetics were performed using a mixture of l2 PFASs in nanopure water. The understanding of adsorption cs is essential as it reveals information on adsorbent doses and required contact times that are relevant for treatment processes. in addition to providing insights into PFOA and PFOS uptake, this panel study also allowed assessment of performance against other PFASs such as GenX and short- and long~chain PFASs in order to determine pectrum PFAS removal lities of these polymers. The results summarized in Fig. l show the removal percentages for each PFAS at 30 mm and 48 h contact times. These experiments were conducted in triplicate with ~l pph of each of the 12 PFASS in re water at a polymer loading of l0 mg/L. l experiments were also performed with no adsorbent and reported removal percentages are corrected for any losses observed during the control ments. All polymers were sieved with 230 mesh. {(130167} lmpressively, the two derivatives of TFN—CDP-l- (namely, 1343443363 and MBul ~037 made from 3 and 6, eq. of choline chloride. respectively) demonstrated the best removal performance of all polymers tested, with near complete removal of all l’FASs in the panel. Over min, MB—l—Q37 displayed effective removal of GenX and short~chain l’FASs, in addition to PFOA and PFOS. presumahly due to its higher quaternary ammonium loading (Fig. 2 9 {till 163} After performing initial screening under the panel study, removal assessments were narrowed to select polymers using a binary mixture of PFOA and PFOS ("l‘ahle 10). ln this specific task, all tion experiments were conducted with 0.5 pph of PFOA and l pph of PFOS at a polymer loading of lt‘i mg/L. Control ments were performed with no adsorbent and all measurements were done in triplicate. Samples from each on were taken for analysis at predetermined time points: 0, 0.5g 2., 4., 8, and 24 h. Polymers selected for these measurements were SL—l—Gl 0A, (TDD, Mild—036 (TFN+CC), and hClB—l —03’7 C). All the polymers tested trated great removal of PFQS over 24 he but l 0A (Till) and two TFNMCDPWL derivatives displayed high l (>90%) in only '30 min. As for removal of PFOA, even though Mid—01014 (TDT) showed similar performance to the panel study; l‘vle—l —036 and M84 ~03? outperformed the other two polymers in terms of both kinetics and removal capacity over 24 h.
Table l0: Removal data of selected polymers for PFOA (0.5 pph) and PFOS ( l pph) mixture. stud-9199. 2,4-TD! 59% 79% 91% 94% 95% M94 -999 TFN+co 93% 99% 99% 99% 99% MB—t "99? Tern-cc 99% 99% 99% 99% 99% set-919A 2,4—TD3 99% 99% 9?% 99% 99% MB—t "999 Tern-cc 99% 97% 99% 99% 99% M94 -99? TFN+co 95% 99% 99% 99% 99% } ollutant Adsorption Studies {(130179} $421) is known to form a stable inclusion complex with rnicropollutants. EPA and MO were chosen as model compounds to study the uptake of neutral and negatively charged micropollutants, respectively, for understanding the adsorption mechanism in e chloride— modified 'l‘lFNuCDP polyniers. Furthermore, fitting the mi cropollutant adsorption data as a function of concentration to a Langmuir model ions l and 2) enables the determination of the thermodynamic parameters of the als tested.
{M13171} 'l'he singleusite Langmuir model that considers neous adsorption surface, is given as qmax ., KL ., Ce 0' ... ‘8 1 + KL . Ce (Equation 1) where qe (mg/Cg) is the amount of MP adsorbed per gram of adsorbent at equilibrium, qmax (mg/g) is the maximum adsorption capacity of adsorbent at saturation, KL (L/mg) is the equilibrium constant and C3 (mg/L or ppm) is the concentration at equilibrium. The dualusite Langmuir model that takes the two distinct adsorption sites into account, is given as gmaXJ ‘ K143 ° Co qmaxz ’ K52 ' Ce qe + 1 ’l' Km ‘ Ce 1 + Km " Ce (Equation 2) where qe (mg/g) is the amount ofMP adsorbed per gram of adsorbent at equilibrium, :3."wa and Qmaxo (mg/g) are maximum adsorption capacities of adsorbent for each site at saturation, K[4,1 and Km (L/rng) are equilibrium constants and are {mg/L or ppm) is the concentration at brium. By fitting the experimental adsorption data using nonlinear regression, quad and KL parameters can he obtained. Single~site Langmuir model was determined to he suitable for fitting the EPA adsorption data, whereas MO adsorption data were best fitted using the dual~site model. {(130172} For choline chloride—modified ’lFNmCDl’ polymers, rnaximurn M0 capacities (9mm) of 46.6 and 78.8 mg/g were found for rs made with l5 and 3.0 equivalents of choline chloride, respectively, for the first tion site (Table l I, Fig. 8). The second adsorption site (aiming) displayed rnaximurn e capacities of 37.3 and 33.0 nig/g, both of which are quite similar to the maximum capacity of unmodified TFNuCDP (grim 37.6 mg/g). This data, as well as similarities hetween K1; and K12 values, suggests that the second adsorption site in choline chlorideuniodilied TEN—CD? polymers is associated with MG adsorption within the CD cavity.
The comparison between K1.,1 and K112 values also indicates a significantly stronger first adsorption site which likely originates from the interaction of anionic MO molecules with quaternary ammonium sites. BPA adsorption data were fitted using a singlemsite Langmuir model and similar K1 values were determined, for all three polymers, indicating the presence of similar adsorption site for a neutral molecule. Maximum EPA capacities of llZl and, l00.l nig/g were found for the two choline chlorideunodified 'l‘FN—CDP rs and a ty of l06.l mg/g was ined for the unmodified 'l'li‘NnCDl’ (Table ll; Fig. 9). y, these saturation uptake values are in good agreement with the density of CD sites in these polymers. This observation also suggests that EPA adsorption occurs within the cavity of CDs.
Table l l: Langmuir fitting parameters for EPA and MO adsorption ECDl EN‘I Gale. rima for Sale. qnnx for Calotmal Sampie MP qmw Km om: Km a? (mmmrsl. lmmellgl. [CDllmaisl [Mime/s)+ qmaxlms/al MB051 (15 en CC) M0 46.6 27.9 37.3 0.37 0.0828 0 48 0.15 157 49 206 036 (3 en CC}, MO 78.8 54.4 33.0 0.19 0.9970 0.37 0,63 121 205 327’ ., [CD] (talc. qmax for Cale. total Qmax KL R" lmmnllsl, {Wilma-'91. . 11W (mo/st TFN-CDF‘ MO 37.6 0.02 0.9828 0.51 167’ 107 M84051 (1.5 on GO) EPA 112.1 0.10 0.9711 0.48 109 109 M81036 (3 eq (:0) EPA 100.5 0.09 0.9651 0.37 84 84 P BF’A 106.1 0.14 0.9714 0.51 118 116 Example 4: Synthesis and PEAS l ty of e chloride—modified ?mCD—Tlll polymer {00173} ?nCl) (2 g, 1.76 rnmol, l eq.) was dissolved, in 5 mL Elli/ll? in a 20 mL llation vial equipped with a magnetic stir bar at a stir rate of 400 rpm and a temperature of 80 "C. 4 g Choline chloride was dissolved, in 110 mL DMSO at 80 °C to achieve a concentration of 0.4 g/inL.
A variety of stoichiornetric ratios of choline chloride solution ((03075 ntL, 0.1230 g, 0.5 eat), 0 nil..., 0.2460 g, l, on), (09225 niL, 0.369 g, 1.5 eq.) or (1.2300 nil..., 0.492 g, 2 eq.)) was added to the B—Cl) solution at 80 °C, After mixing for 5 min at 80 0C, toluene diisocyanate (2.94— 'lBl, l.84l7 g, l057 mmol, 6 ed.) was added suhsequently. Air bubbling was observed after the diisocyanate addition, presumably due to the moisture in the reaction system. After about l min when huhhling suhsided, the vial was . After 3 h, the reaction was d by adding l0 rnL of methanol and turning off the heating. White powder product precipitated out after methanol addition. The e was erred to a 50 ml; opylene centrifuge tube. After fuging, the solvent was decanted and the crude product was washed with water (4t) mL X 2 times), and methanol (40 ml; X 2 times). ln each wash cycle, the mixture was stirred for 30 min and followed by centrifuge. In the final cycle, the product in methanol was filtered under vacuum and dried at 80 °C overnight. Fig. l0 shows a 1ll NMR spectrum of a choline chloridenmodified B—CD—TDI polymer made with l:6:l molar lents of B—Cl):'l'l)l:choline chloride in 5 mL of DMF at 80 0C for 3 hours. The appearance of urethane and urea groups at 775—96 ppm indicates successful incorporation of e chloride into the polymer. The following chemical shifts are also found in thelH l‘leR spectrum: 6.75—7.75 ppm ns from the aromatic ring in TDD; 556 pm (protons from ~OH groups that are attached to C2 and C3 in SSE); 4,8 -5 ppm (protons that are ed to Cl in 5431)); 4.25—4.75 ppm (protons from ~08 groups that are attached to err in BmCD); All ppm (protons from —O~CH2— groups in e chloride); 3.5—4 ppm ns that are attached to CZ~C6 in B~CD); 3.3—3.5 ppm (protons from water); 3.18.2 ppm (protons from €83 groups in choline chloride); 2.5 ppm (DMSO); l.9~2.l ppm (protons from — CH3 groups in TDl); Peaks noted with star are from residual solvent. Fig. ll shows a comparison of a choline chloride—modified B-CD—TDE polymer and a DI polymer, with the key difference being the broad peak centered around 3, l3 ppm. Sharp pealrs at all ppm and 3.l ~32 ppm originates from unreacted choline chloride. Fig. 12 shows a comparison between three choline cl'iloride-modit‘ied BwCD-TDI polymers with different choline chloride loading amounts, which supports the position that with increasing amount of choline chloride, the pealr intensity increases at 3. l 3 ppm. {98174} in accordance with the synthetic procedure outlined above, a variety of rs were made with varying stoichiometric equivalents as shown below in Table l2. Furthermore, the polymers were tested for their PFOA uptalre. The results show that by incorporating choline chloride into a ButiD—E‘Dl polymer, cationic charge can he added to the polymer in a controlled fashion, resulting in PFQA uptake increasing from 70% to 99% when compared to Shul u0l 0A polymer ('lahle l2). See also Fig. l3.
Tabie 12: Synthesis of ehoiine ehiorideuniedified ?mi’CDuTDi polymers . hc PFDA Meterin? Seivent Ti013) Time YBEM. Notes ratio uptake" SL—Z-DO4E 1:61) DMF 80 3 h n/a We Get SL—2-005A 1.6.0.5. , a DMF 50 3 h n/a ma ESL—$0053 1:621 DMF 80 3 h 73% 98% SL—Z—GO?C i:6:t.5 DMF 80 3 h 73% 99% 3050 1:652 DMF 80 3 h 60% 99% *500 not PFOAHOGG pot PFOS, 10 mg/L poiymer loading at 05 h.
LENTS {WWSE While the present invention has been described in coniunetien with the specific enibediinents set forth above, niany alternatives modifications and other variations thereef will be apparent to these of Ordinary skiii in the art. Ail such aiternatives, ications and variations are intended to faii within the spirit and scope 0f the present invention References (:1) Richardson, S. 11.; Ferries, '1‘. A. Anal. Chem. 21118, 90, 398—428. 1:2) Carpenter, C. M. G; Hel‘oling, D. E Environ. Sci. inclino]. 21118, 52, 6187—6196. 1:3) Barry, V. Winquist, A. Steenlend, 14;. Environ. Health ci. 2111.3, 121, 1313—1318. 1:4) (13110, V; Leonardi, G; Geiiser, B, Lopez—Espinose, MAJ; Frisbee, S. 1.; Karlsson, L; nian, A M.; F1etcher, '1". Enir-‘iron. Health Pei/aspect. 21112, 1211, 655—660. (51 Meizer, 113.; Rice, N; Dep1edge, M. 151.; Henley, W. E; Galloway, '1‘. S. emu-on. Health Perispeci. 211111, 118, 686—692.
De‘Witt, 1. C. Dietert, R. R, Ed; Mo1ecu1ar and1ntegratiye Toxicology; Springer International Publishing: Chem, 2015.
DiainaritimKandarakis, F.; ignon, 1:11; Giuclice, L. C; Hauser, 11.;1’1'ins, G. S; Soto, A. M.; Zoeller, R. T, Gore, A C. Endocr. Rev. 211119, 30, 293—342.
Vajda, A M.; Berber, L. 11.; Gray, .1. L.; Lopez, 13‘. M.; Woodling, .1. 11.; , D. O.
Environ. Sci. Technol. 211118, 42, 3497—3414. "fetteault, G. R; Bennett, C. 1.; Shires, K; Knight, 13.; Servos, M. R; er, M. E.
Aqua; onicoi. 21111, [04, 278—290.
Gegné, F.; Bouchard; 13.; Andre; C; Farcy, F... Fournier; M. Comp. Biochem. l. — C Toxicol. Pharmacol. 21111, 153; 99—106. ee, A; Smith, 11. 1.; Xian, L; Ling, Y; Helbhng, D. F; Dichtel, 1V. R. Nature 21116, 529, 1911—1911.
AlzatemSaanhez, 1). M.; Smith, 11. 1.; Alsbaiee; A. Hinestroza, 1. F.; Dichtel; W. R. Chem. r. 21116, 28, 8340—83416.
Ling, Y; Klenies, M. 1.; Kim, 1...; Alsbaiee, A; Dichtel, W. R; He1bling, D. F n.
Sci. chnnoi. 21117, 5], 7590—7598.
Xian, L.; Ling; Y; Alsbeiee, A; Li; C; Helbling, F). F..; Dichte}; ‘W. R. J. Am. Chem. Soc. 2017, 1:19, 7689—7692. 1i, W; Xiao, L.; Ling, Y; Ching, C; Matsumotc; M; ; R. F.; Heibiing, D. F, Dichtel; W. R. J. Am. Chem. Soc. 21118; 141), 12677—12681.
Klemes, M. 1.; Ling; Y; Chiapesco, M; Alshaice, A; Helbiing, D. F..; Dichtei; W. R- Chem. Sci. 21118; 9, 8883—8889.
Li, C; Klemes; M. 1.; Dich‘tei, W. R; 11e1bhng, D. F. J. Chroniaiogr. A 21118, 154']; 52— D’Agostino; L. A; Mahiiry; S. A. Environ. Sci. Techno]. 21117, 51, 13613.
Barzern?anson; K. A; Roberts, S C; Choyke, S; Oetjen; K; McAlces; A; l; N; McCrindle, R; Ferguson, F. L; Higgins, C. 13.; Field, 1. A. Environ. Sci. chnnoi. 21117, 51, 2047—2057.
Breysse, P. N. U.S Dcparicmcni in andHuman Services." Agencyjor beic Substances and Disease Registry: libxicologicai ejor Pcn?uoroailqvis. 2018.
Hu, X. C; s, 11. Q; Lindstrorii, A 8.; Britten, '1‘. A; Schaider, L. A; Grandiean, 13.; Lohrnariii, R; Cerigrian, C. C, Blurn, A; Balan, S. A; et al. Environ. Sci. Technol.
Len. 21116, 5’, 344--—~350.
Kannen, K; Corsoiini, S; Felaiidysz, 1.; Fillnienn, G; Rainier, 14;. S; Loganaihari, B. (1;; Mohd, M. A; Olivero, 1.; Van Wouwe, N, Yang, 1. 1-1.; et a}. n. Sci. Techno]. 211114, 38, 4489—4495.
Sun, M.; Areva1o, E; Strynar, M.; Lindstroni, A; Richardson, 1%.; Kearns, B; Pickett, A; Smith, C; Knappe, D. R. U. Environ. Sci. Technol. Leif. 21116, 3, 415—419. <24) Eschauzier, C; Beerendmk, E, ScholteuVemendaai, P; DEE Voogt, P. Envimn, Sci.
Technai. 2912, 46, 1708"} '7} 5. <25) Kim, L, (Thing, C; Ling, Y; Nasiri, M; , M. 1.; Reineke, T. M; Heibhng, D. E; Dichtei, W. R. (Submitted i0 Chem. Ali/farm". December 2018) ZGEQ, 1~-—9. (26:: Mason, C. R; Maynard—Adam, L; 1-ieard, K. W. 3.; Sat?mis, 8., Budd, P. Ms, Friess, K; Land, 1%.; Bernardo, B, Clarizia, G; Jansen, I. C. Afacmmaiecuies 2614, 4 7, 1921—1029. (27> Vojkovsk, T. Pept. Res, 1993, 8, 7. <28) Mafik, 3.; Song, A; Lam, K. S. I’éiraizedmn Left. 2993, 44, 4319—432(). (29) Buckley, 1).; Henbegt, H. B; Slade, P. J; Chem, SOC, 1957, 4891, 4891. 6 (J1
Claims (27)
1. A porous polymeric material, comprising a plurality of cyclodextrins covalently inked with: (a) a plurality of crosslinks comprising structure (I): , and structure (I) (b) a plurality of crosslinks of formula (I) and a counteranion (X-): formula (I); wherein: A is an aryl or heteroaryl moiety; each R1 is independently selected from the group consisting of H, C1-C6 alkyl, C1-C3 haloalkyl, aryl, heteroaryl, -CF3, -SO3H, –CN, -NO2, -NH2, -NCO, -C(O)2R3, -C(O)N(R3)2, and – halogen; each R2 is ndently H, -OH, -O-metal cation, alkyl, aryl, heteroaryl, -SH, –S-metal cation, –S-alkyl, -C(O)2H, or -C(O)NH2; each R3 is independently –H, –C1-C6 alkyl, –C1-C3 haloalkyl, –aryl, -C(O)N(Ra)(Rb), or -SO2N(Ra)(Rb), and each Ra and Rb is independently H, or C1-C6 alkyl; each W is independently a bond, an ne group, an arylene group, a heteroarylene group, -O-arylene-, q-arylene-, -SO2-arylene-, -NH-arylene-, lene-, -O- heteroarylene-, -(CH2)q-heteroarylene-, -SO2-heteroarylene-, -NH-heteroarylene-, -S- heteroarylene-, CH2)q–)r–, –(–NH–(CH2)q–)r–, –(–S–(CH2)q–)r–, , or , wherein q is 0-100 and r is 1-100; each L is independently selected from the group consisting of –O–, –S–, –N–, C1-C6 alkylene, C1-C3 haloalkylene, , , , , , , and ; each Z is a cationic moiety; A’ is a covalent bond to A; Z’ is a covalent bond to Z; x is 0-8; y1 is 1-4; y2 is 1-4; y3 is 0-4; y is 0, 1, or 2; each M is independently a linking moiety selected from the group consisting of –O–, –S–, –N–, C1-C6 alkylene, C1-C3 haloalkylene, , , , , , , and ; is a point of attachment to the plurality of cyclodextrin carbon atoms; B’ is a covalent bond to the phenyl ring of structure (I); and * is a covalent bond attached to .
2. The porous polymeric material of claim 1, wherein the cationic moiety is –N(R3)3+, – P(R3)3+, –S(R3)2+, or oaryl+, wherein each R3 is independently –H, –C1-C6 alkyl, –C1-C3 haloalkyl, –aryl, -C(O)N(Ra)(Rb), or -SO2N(Ra)(Rb), and each Ra and Rb is independently H, or C1-C6 alkyl.
3. The porous polymeric material of claim 2, wherein the cationic moiety is –N(R3)3+.
4. The porous polymeric material of claim 3, wherein the ic moiety is –N(CH3)3+.
5. The porous polymeric material of claim 2, further comprising a plurality of linkers of ure (IV): structure (IV).
6. The porous ric material of claim 5, wherein each cyclodextrin is ß-cyclodextrin.
7. The porous polymeric material of claim 1, wherein the plurality of crosslinks have a cationic moiety and a ranion (X-) and comprise structure (II): structure (II), wherein each M is independently a linking moiety selected from the group consisting of –O–, –S–, –N–, C1-C6 alkylene, C1-C3 haloalkylene, , , , , , , and ; and wherein y is 0, 1, or 2.
8. The porous polymeric material of claim 7, wherein each M is –O–.
9. The porous polymeric material of claim 8, wherein X- is Cl--.
10. The porous polymeric material of claim 7, wherein X- is Cl--.
11. The porous ric material of claim 7, further comprising a plurality of cyclodextrins crosslinked with a plurality of inks of structure (III): structure (III)
12. The porous polymeric material of claim 11, wherein each cyclodextrin is ß-cyclodextrin.
13. The porous polymeric material of claim 7, further comprising a plurality of s of structure (IV): structure (IV).
14. The porous polymeric material of claim 13, wherein each cyclodextrin is ß-cyclodextrin.
15. The porous polymeric material of claim 7, wherein each extrin is ß-cyclodextrin.
16. The porous polymeric material of claim 1, wherein each M is –O–.
17. The porous polymeric material of claim 16, wherein X- is Cl--.
18. The porous ric material of claim 1, further comprising a plurality of cyclodextrins crosslinked with a plurality of crosslinks of structure (III): structure (III)
19. The porous polymeric al of claim 18, further comprising a plurality of linkers of ure (IV): structure (IV).
20. The porous polymeric material of claim 19, wherein each cyclodextrin is ß-cyclodextrin.
21. The porous polymeric material of claim 18, wherein each cyclodextrin is ß-cyclodextrin.
22. The porous polymeric material of claim 1, wherein each cyclodextrin is ß-cyclodextrin.
23. A method of purifying a fluid sample comprising one or more pollutants, the method comprising contacting the fluid sample with the porous polymeric material of claim 1, whereby at least 50 wt. % of the total amount of the one or more pollutants in the fluid sample is adsorbed by the porous polymeric material.
24. A method of purifying a fluid sample comprising one or more pollutants, the method comprising contacting the fluid sample with the porous polymeric material of claim 7, whereby at least 50 wt. % of the total amount of the one or more ants in the fluid sample is ed by the porous polymeric material.
25. A method of removing one or more compounds from a fluid sample or determining the presence or absence of one or more compounds in a fluid sample comprising: a) contacting the sample with the porous ric material of claim 1 for an incubation ; b) separating the porous polymeric material after the tion period from the sample; and c) heating the porous polymeric material separated in step b), or contacting the porous polymeric material separated in step b) with a solvent, thereby releasing at least a portion of the compounds from the porous ric material; and d1) optionally isolating at least a portion of the compounds released in step c); or d2) determining the presence or absence of the compounds released in step c), wherein the presence of one or more compounds correlates to the presence of the one or more compounds in the sample.
26. A solid-phase extraction device comprising the porous polymeric al of claim 1.
27. A solid-phase extraction device comprising the porous polymeric material of claim 7. ?x;a? ?x? '1‘ - ‘~ :3}:
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NZ794040A NZ794040B2 (en) | 2020-02-13 | Charge-bearing cyclodextrin polymeric materials and methods of making and using same |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962805505P | 2019-02-14 | 2019-02-14 | |
PCT/US2020/018149 WO2020168104A1 (en) | 2019-02-14 | 2020-02-13 | Charge-bearing cyclodextrin polymeric materials and methods of making and using same |
Publications (2)
Publication Number | Publication Date |
---|---|
NZ778750A NZ778750A (en) | 2023-09-29 |
NZ778750B2 true NZ778750B2 (en) | 2024-01-04 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN114015127B (en) | Charged cyclodextrin polymer materials and methods of making and using the same | |
US11001645B2 (en) | Charge-bearing cyclodextrin polymeric materials and methods of making and using same | |
WO2018200857A1 (en) | Grafted porous cyclodextrin polymeric material and methods of making and using same | |
Salama et al. | Synthesis of N-guanidinium-chitosan/silica hybrid composites: efficient adsorbents for anionic pollutants | |
WO2020167375A1 (en) | Post-synthetically modified cyclodextrin polymeric materials and methods of making and using same | |
US10155217B2 (en) | Endotoxin adsorbent | |
NZ778750B2 (en) | Charge-bearing cyclodextrin polymeric materials and methods of making and using same | |
NZ794050A (en) | Charge-bearing cyclodextrin polymeric materials and methods of making and using same | |
NZ794040A (en) | Charge-bearing cyclodextrin polymeric materials and methods of making and using same | |
NZ794040B2 (en) | Charge-bearing cyclodextrin polymeric materials and methods of making and using same | |
Alam et al. | Crosslinked Chitosan-Sulfonated Polyphenylsulfone Electrospun Nanofibers: A Highly Water-Stable and Versatile Adsorbent for Organic Dye Removal | |
Rawat | Morphology and Functionality of Polyvinyl Alcohol based Nanofibers |